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Abstract 
Microdialysis is a sampling technique that can be employed to monitor 
biological events in vivo and chemical reactions in vitro.  When it is coupled to an 
analytical system, microdialysis can provide near real time information on the time 
dependent concentration changes of analytes in the extracellular space or other 
aqueous environments.  Online systems for the analysis of microdialysis samples 
enable fast, selective and sensitive analysis while preserving the temporal 
information. Analytical methods employed for on-line analysis include liquid 
chromatography (LC), capillary (CE) and microchip electrophoresis and flow-through 
biosensor devices. This dissertation is focused on the development of microchip 
systems coupled to microdialysis sampling for online near-real time monitoring with 
high temporal resolution for the analysis of amino acid neurotransmitters in vivo. 
Fluorescence detection was utilized for all the studies. Also, naphthalene-2,3-
dicarboxaldehyde (NDA) and β-mercaptoethanol (β-ME) or CN- are used as the 
derivatization reagents for rendering the amino acids fluorescent. 
Initial studies were performed to evaluate a twin-t design with a 3 cm 
separation channel that incorporated on-column derivatization with NDA and β-ME. 
Biogenic amines and peptides were separated on chip demonstrating the feasibility of 
online microdialysis sampling with online derivatization and analysis in vitro.   
Subsequently, the chip was further modified by incorporating a 20 cm 
serpentine separation channel and excitatory amino acid neurotransmitters (glutamate, 
aspartate) were separated from other analytes in rat brain microdialysis samples. 
 vi
Next, precolumn derivatization was incorporated into the chip and online in vivo 
experiments were performed for the continuous analysis of glutamate from rat brain 
microdialysis sample. Also, fluorescein was included in the experiment for the 
possibility to simultaneously monitor the permeability of the blood brain barrier 
(BBB) along with changes in levels of excitatory neurotransmitters during online 
analysis applied to the rat stroke model. The chip was further modified and optimized 
for experiments that require fast injections and separations thereby attaining high 
temporal resolution. This work described an online microdialysis-microchip system 
that can be used for monitoring neurochemical events that involve fast changes in 
analyte concentration in the brain. 
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1.1 Introduction 
There are very few tools that can be used to continuously monitor biological 
events with high temporal resolution.  Microdialysis is a powerful sampling technique 
that makes it possible to continuously monitor the concentrations of biological 
molecules and other substances both in vivo and in vitro.  Although the primary 
applications of microdialysis sampling have been in the area of neuroscience research 
[1], it has also been extensively employed for other pharmaceutical applications.  
These include the investigation of the transdermal delivery of drugs [2], tissue 
pharmacokinetics [3], and regional metabolism of drugs in tissues [4,5].  
Microdialysis probes have been placed in virtually every tissue and organ in 
the body including the liver [6,7], heart [8,9], skin [4,10], blood [11,12], placenta 
[13], stomach [14,15] and ear [16].  Fig. 1.1 shows the microdialysis sampling 
process.  These probes act in a manner similar to a blood vessel, allowing substances 
to be removed or delivered to a specific site through diffusion with no net fluid loss.    
A probe containing a dialysis membrane with a specific molecular weight cutoff is 
implanted in the physiological region of interest.  It is then perfused with a fluid that 
is similar in ionic strength and composition to the extracellular fluid being sampled.  
Small molecules in the extracellular fluid that are not present in the perfusate diffuse 
across the membrane based on their concentration gradient and are then transported to 
the analysis system.  Likewise, compounds in the perfusate that are not present in the 
extracellular fluid can be delivered directly to the physiological site of interest.  


















site. This feature can be very useful for looking at site-specific release of 
neurotransmitters, observing regional metabolism of neuropeptides [17,18], or 
comparing the metabolism of antineoplastic agents in tumor versus healthy tissue 
[19]. 
Over the past decade, a considerable amount of research has been conducted 
on the development of online analytical systems capable of analyzing microdialysis 
samples.  The direct coupling of the analytical system to the microdialysis sampling 
system allows continuous near real-time monitoring of biological and other processes 
in vivo and in vitro.  Online methods usually provide better temporal resolution and 
precision than offline analyses. This chapter addresses some recent advances in the 
development of hyphenated systems incorporating microdialysis with microanalytical 
systems with particular emphasis on microchip based devices.  
 
1.1.1. Microdialysis probes 
Fig. 1.2 shows some typical microdialysis probe configurations.  A concentric 
cannula design (Fig. 1.2A) is normally employed for neurochemical studies.  These 
probes are composed of stainless steel and are implanted into the specific brain region 
of interest using a guide cannula.  A typical probe used for rat brain studies is 15 mm 
long with an outer diameter between 200 and 500 microns.  The dialysis membrane is 
located at the end of the concentric cannula and is usually from 1 to 4 mm in length. 
Probes are also available for brain sampling in mice.  The mouse probes employ 
shorter shafts (7–12 mm) and have outer diameters between 220 and 380 microns.   
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For sampling soft tissue, a linear probe can be employed (Fig. 1.2B).  These 
probes consist of a microdialysis membrane (4–10 mm) placed between two pieces of 
flexible tubing.  Soft tissue is more homogeneous than brain tissue and, therefore, 
spatial resolution is not as important. Thus, the surface area of these probes is 
generally larger than that of the brain probe. This type of probe has been used for 
sampling from liver, muscle, heart and skin.  
For blood sampling, a flexible probe has been developed (Fig. 1.2C).   This 
type of probe was first described by Telting-Diaz et al. [20].  Its design is similar to 
that of the brain probe and consists of two pieces of fused silica tubing attached to the 
dialysis membrane.  The flexible probe can bend when the animal moves, minimizing 
any damage to blood vessels. In general, analyte recoveries are higher from blood 
than from the stagnant interstitial fluid [21].  
A shunt probe has also been developed for sampling from moving fluids in 
vivo or in vitro (Fig. 1.2D) [22].   This probe has been used to sample bile in awake, 
freely moving animals.  For these experiments, the bile duct is cannulated and bile is 
sampled by a second dialysis membrane filled with fluid of similar ionic composition 
running in the opposite direction.  This probe has also found use for  desalting protein 
samples prior to introduction into a mass spectrometer [23]. 
Most microdialysis probes have molecular weight cut-offs between 20,000 
and 60,000 Da.  Recoveries decrease dramatically for most compounds of about 
10,000 Da molecular weight.  In cases of extremely fast sampling, diffusion across 









Fig. 1.2: Microdialysis probes. A. Cylindrical probe for brain. B. Linear probe for 
peripheral tissues. C. Flexible probe for intravenous use. D. Shunt probe for bile duct 
sampling (Fig. 2A–2C: CMA product catalogue; 2D: Huff et al. [22]) 
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 circumvent these problems and make it possible to sample larger molecules as well 
as obtain higher recoveries of small molecules, Shippy’s group has developed a low-
flow, push-pull perfusion device [25].  The push-pull perfusion probe consists of a 
27-gauge stainless steel cannula that is perfused with saline.  A fused silica capillary 
acts as the inner cannula and is used to withdraw fluid from the extracellular space; 
the fluid is then transferred to the analysis system.  Flow rates using this method are 
from 10 to 50 nL/min and analyte recovery is 100%.  
  
1.2. Microdialysis sampling  
Microdialysis has several advantages for sampling biological tissues and 
fluids, especially when combined with separation-based analytical methods.  The 
resulting samples are most commonly composed of an aqueous salt solution that 
contains only small molecular weight analytes.  Cells and macromolecules are 
excluded by the dialysis probe so centrifugation or protein precipitation steps are not 
required prior to analysis.  In addition, because sampling is based on diffusion of 
substances across the dialysis membrane, no fluid is removed.  Therefore, it is 
possible to continuously monitor substances in the extracellular fluid of the brain and 
other tissues for several months [26,27].  The animal can also serve as its own 
control.  This latter advantage is particularly important for tissue distribution studies 
where the normal protocol is to sacrifice several animals at each time point to obtain 
enough data to make statistically valid conclusions.  
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Another significant advantage of microdialysis is that studies can be 
performed in awake, freely moving animals.  This is especially important in studies 
that correlate brain drug concentration and/or neurotransmitters with behavior.  
Because of the small size and relatively noninvasive nature of the microdialysis 
probes, it is also possible to put multiple probes in a single animal.  It is therefore 
possible to measure blood, brain, and tissue concentrations of drugs or endogenous 
substances simultaneously.  If the animal is awake, these measurements can be 
correlated temporally with behavior.   
A very nice example of the use of multiple probes in a single animal is shown 
in Fig. 1.3 [28].  In this experiment, the rat was given an i.v. injection of 
methylphenidate (Ritalin).  Brain and blood sampling was accomplished using a 
concentric cannula probe and flexible probe, respectively.  Dialysates were collected 
offline, and the concentrations of methylphenidate and dopamine in both the brain 
and blood were determined using liquid chromatography with electrochemical 
detection.  In this manner, it was possible to measure the transport of Ritalin across 
the blood-brain barrier as well as its effect on catecholamine release.  Lastly, by using 
a “RatTurn,” the extracellular concentration of these substances could be directly 
correlated with the overall activity level of the rat. For long-term-microdialysis 
studies, careful consideration should be made regarding the tissue damage associated 
with probe implantation. Fibrosis or gliosis can occur after several days of probe 
implantation [29]. Grabb et al. compared the effects of acute (2–4 hours) and chronic 
(24 hours) implantation of microdialysis probes. They reported the occurrence of 
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Fig. 1.3: Simultaneous monitoring of dopamine and methylphenidate (MPD) from 
multiple probes. The filled squares represent MPD from jugular dialysate, the filled 
circles represent MPD from brain dialysate, and the filled triangles are % dopamine 
with respect to basal. X-axis is the time from dosing in minutes. (From Huff et al. 
[28]) 
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inflammation, hemorrhage and edema surrounding the microdialysis probe following 
24 hours of implantation; they also observed the development of fibrin-like polymer 
around the probe (gliosis). The extracellular edema increases the diffusional distance 
between the probe and the extracellular fluid, and this fibrin-like polymer can create a 
physical barrier between the dialysis probe and the extracellular fluid surrounding the 
cells [30]. Both of these factors can adversely affect recovery of the probe. In a 
separate study based on local cerebral blood flow (LCBF) and local cerebral glucose 
metabolism (LCGM), Benveniste et al. recommended a 24-h period of recovery after 
probe implantation [31] 
The integrity of the BBB following probe implantation is also a factor for 
discussion. Studies conducted using autoradiography with 14C-AIB (which does not 
cross the BBB under normal conditions) as well as transport characteristics of 
hydrophilic and moderately lipophilic drugs (following IV injection) postsurgery 
indicates that the BBB integrity is maintained overall [32,33]. However, other studies 
using Cr-51-EDTA transport have shown a significant effect of probe implantation on 
BBB permeability [34].  
 
1.2.1 “Offline” vs. “online” sampling 
The analysis of microdialysis samples can be divided into two general 
categories, i.e., offline and online analyses, the former of which is the most common.  
For offline analysis, a specified volume of sample (usually 1–20 μL) is collected in 
vials or tubes for later analysis.  The temporal resolution that can be obtained in these 
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experiments is usually determined by the microdialysis flow rate, analyte recovery, 
and the sensitivity of the analytical method.  At the typical microdialysis flow rate of 
1 μL/min, most offline experiments have temporal resolutions from 5–10 min.  An 
exception to this is if the analyte concentration is very high. Then smaller volume 
samples can be collected and diluted prior to analysis. However, in general, sample 
volumes of less than one microliter become very difficult to manipulate offline due to 
problems with surface tension and evaporation.  
Online sample analysis offers several potential advantages over offline 
analysis.  In an online system, the sample collection, manipulation, injection, and 
analysis steps are all integrated on a planar device in a continuous, streamlined 
fashion. Therefore, problems related to handling submicroliter volumes of sample 
(sample loss, mislabeling, evaporation, and surface tension) as well as sample 
degradation that can occur with sample exposure to air (e.g., ascorbic acid and 
catecholamines) can be avoided [35,36].  Also, such systems are usually capable of 
manipulating and analyzing submicroliter sample volumes, which allow high 
temporal resolution analysis to be performed.  Such studies can yield continuous near 
real-time data, which provide immediate feedback on the biological process under 
investigation.  When microdialysis sampling is directly coupled to a separation and 
detection method, it yields a separation-based sensor that can be used to monitor 




1.2.2 General considerations 
When developing an online assay based on microdialysis sampling, several 
parameters must be taken into consideration. These parameters include: 
i. Perfusion flow rate 
ii. Volume of sample available for analysis 
iii. Concentration range of analyte in the sample   
iv. Sensitivity and limit of detection of the analytical method scheme 
v. Speed of analytical method 
vi. Frequency of analysis required to draw valid conclusions (temporal resolution 
desired) 
 
1.2.2.1 Perfusion flow rate and sample volume for analysis 
Analyte recovery in microdialysis is defined by the overall mass transport of 
the analyte across the probe. It can be expressed as the ratio of concentration of the 
analyte in the dialysate to that present in the extracellular space or sampling solution.  
The amount of analyte that diffuses into the probe is a function of the concentration 
gradient that is produced across the dialysis membrane.  This concentration gradient 
is established and maintained by continuously infusing the probe with fresh perfusate 
(e.g., aCSF in brain probes).  The analytes of interest passes through the probe and is 
transported to the outlet end for collection or analysis.  Higher recoveries (more 
concentrated samples) are obtained when probes are perfused at lower flow rates 
because this allows more time for the analyte to diffuse from the extracellular fluid 
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across the membrane into the perfusate.    Typical microdialysis perfusate flow rates 
are between 0.5 and 2.0 μL min–1.  Recoveries for small molecules are usually 
between 10 and 40% at these flow rates.  If a flow rate of 100 nL min–1 is employed, 
the relative recovery approaches 100% [37]. However, use of these very low flow 
rates places a substantial burden on the analytical method.  The method must be able 
to analyze submicroliter samples if one minute temporal resolution is desired as well 
as provide the requisite sensitivity to detect the analyte at this concentration.  As seen 
from Fig. 1.4, the absolute recovery (mass of substance recovered in a particular 
period of time) increases with higher flow rates. Therefore, with systems that require 
relatively large sample volumes (e.g., HPLC), it is better to sample at higher flow 
rates. This will lead to higher absolute recoveries as well as allow more frequent 
injections of sample.  
The major applications of microdialysis are to measure the in vivo 
concentration of endogenous (neurotransmitters, peptides) or exogenous (therapeutic 
drugs) compounds. Therefore, analyte recovery is an important consideration in 
microdialysis experiments. Recovery can be described by the following equation: 
 
R = 1 – exp (-1/(Qd(Rd + Rm + Re)) 
 
where Qd is the volumetric flow rate of perfusate, Rd, Rm and Re are the resistances of 
dialysate, membrane and extracellular space, respectively, to the mass transfer of 























Fig. 1.4: Relative and absolute recoveries of dopamine as a function of flow rate (from 
“Microdialysis – principles of recovery” by Agneta Eliasson, 1991). 
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includes factors such as the rate of diffusion of the analyte of interest through the 
extracellular space as well as metabolism and other active reactions that the analyte 
may undergo. Rm incorporates the probe-related factors such as probe dimension, 
MW cutoff and the diffusion coefficient of the analyte across the probe membrane. 
Rd takes into consideration the diffusion of the analyte in the microdialysate [21,37].  
It is generally assumed that Rm>>Re, which implies that recovery information 
obtained for a probe in vitro can be applied to in vivo experiments. However, the 
caveat attached to such an assumption is the fact that the diffusion of the analyte from 
distant extracellular space to the area around the probe can be slow and is dependent 
on the diffusion coefficient of the analyte(s) in the extracellular matrix. For large 
peptide neuromodulators, such sluggish diffusion can affect the recovery. In 
particular, peptides can also undergo metabolism and other kinetic processes in the 
brain before reaching the probe membrane. Other considerations include determining 
the effects of loss of tissue integrity due to surgery and changes in blood flow and 
immunological reactions following insertion of the probe. 
For many in vivo applications, enough information can be obtained by 
monitoring the percent change of analyte with respect to the basal experiment 
concentration. In these experiments, the untreated animal acts as its own control. 
These are usually performed to demonstrate proof-of-concept rapid changes in 
analytes after some intervention in which the outcome is known a priori (change due 
to some neurochemical pathway) [21]. During such experiments, it is generally 
assumed that that the probe is performing consistently throughout the duration of the 
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experiment. However, careful consideration needs to be given to this assumption 
during the course of the experiment. For example, a tissue reaction could be triggered 
during perfusion that could lead to altered analyte concentrations and erroneous 
conclusions. Monitoring changes in endogenous compounds is an excellent 
application for online experiments that can make measurements with high temporal 
resolution on a single, awake animal where the animal can serve as its own control.  
Several additional factors need to be taken into consideration if more accurate 
in vivo concentration is warranted (such as PK studies). Some of those factors include 
the probe membrane type and its size, location of sampling probe, and flow rate. In 
addition, for an accurate assessment of in vivo concentration, the probe must be 
calibrated. There are several methods that have been reported for probe calibration 
with the “no-net flux” as the most popular method [38,39].  In this method, a known 
concentration of analyte is added to the perfusate. The concentration is usually varied 
over a range that is both higher and lower than the expected extracellular 
concentration of the exogenous or endogenous compound. The concentration of the 
analyte in the dialysate is measured and considered to be at the “no net flux” 
condition when there is no exchange of analyte between extracellular space and 
perfusate. This point is considered to be the extracellular fluid concentration. The 
major drawback of this method is the long time required to reach steady-state 
conditions, usually from several hours to a day. Hence, for online systems, this 
method of probe calibration may not be practical due to the tediousness of this 
process. 
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An easier method of probe calibration is called “retrodialysis” or “reverse 
dialysis” and is particularly applicable for in vivo experiments. The underlying 
assumption of this method is that diffusion across the probe membrane is 
quantitatively equal in both directions. This method uses an internal standard whose 
physical, biological, and pharmacokinetic properties closely resemble the compound 
under scrutiny. Such a compound is added at a known concentration to the perfusate, 
and its rate of disappearance is calculated from the equation, 
Recovery (%) = 100 – (100 x Cdialysate/Cperfusate) 
Calibration should ideally be done before an experiment when there is no 
analyte present in the tissue; this is to maintain the membrane concentration gradient 
during the experiment. Also, a thorough perfusion of probe with physiological 
solution should be performed to remove the drug delivered to the tissue during 
retrodialysis [29,40]. Other in vivo recovery estimation methods include the 
“variation of perfusion flow rate method” and the “delivery method” [40]. 
  
1.2.2.2. Temporal resolution 
Temporal resolution can be defined as the smallest increment of time over 
which the change in a dynamic process can be observed. For neurochemical 
experiments, microdialysis is usually coupled online to an instrument with the goal of 
analyzing samples with high temporal resolution.  Many neurochemical events, such 
as neurotransmitter release, occur at a time scale of seconds or less. This results in 
very fast and transient changes in the concentration of substances in the extracellular 
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fluid.  Therefore, the primary objective in such experiments is to analyze samples as 
frequently as possible in order to detect these fast changes; otherwise, the 
concentration change could be missed due to dilution and averaging of the signal in 
the sample.  
In the choice of an analytical method, the first question that needs to be 
addressed is whether the device or the method is sensitive enough to actually detect 
the quantity of analyte(s) present in the small volume of sample generated by very 
fast sampling.  If a probe is perfused at 1 μL/min and the perfusate contains an 
analyte at micromolar concentrations, then the analytical system must have sufficient 
mass sensitivity to detect 1 pmol of analyte if 1 min temporal resolution is desired.  If 
the analytical method is capable of detecting only 10 pmol or higher, this means that a 
much larger sample (10 μL) must be collected in order to measure the analyte of 
interest.  This limits the temporal resolution to 10 min at a flow rate of 1 μL/min.  
In many cases with on-line systems, the temporal resolution of the technique 
is defined by the analysis time.  If the analysis time is longer than the duration of the 
event being measured, then the change will appear digital and appear in the next 
injection.  On the other hand, in those cases where the analysis step is much faster 
than the event being measured, it is possible to detect the change in concentration as a 
function of time.   In this case, the rise time is defined as the time required during for 
the signal to increase from 10% to 90% of maximum intensity [41].  For very fast 
analyses, the rise time becomes dependent on the rate of diffusion of analyte across 
the probe membrane. However, in most cases, it is the dead volume in the system, 
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injection method, and the flow rate of the dialysate that determine how fast a 
concentration change can be measured with an on-line system.    
As mentioned in the previous section, higher analyte recovery can be achieved 
by using very slow flow rates.  At flow rates of 100 nL/min, analyte recoveries of 
100% have been reported [37].  However, the increase in concentration of the analyte 
in the perfusate is offset by the extremely small sample volumes that are generated 
per unit time.  In this case, an analytical method that is both sensitive and capable of 
analyzing submicroliter sample volumes is necessary if 1 min temporal resolution is 
to be obtained.  This is one of the driving forces for the use of capillary and microchip 
electrophoresis for the analysis of microdialysis samples. 
For most online separation-based microdialysis systems (described later in 
this review), analysis is performed on such as amino acid neurotransmitters whose in 
vivo concentrations are relatively high and well within the detection limits of laser 
induced fluorescence (LIF) detection. In such cases, the factor that dictates temporal 
resolution is the time that is required to separate the compounds so that serial analyses 
can be performed without overlapping the analysis peaks from two different runs. In 
other words, the difference in injection time between run 1 and run 2 should ideally 
be the separation time for run 1 so that as soon as run 1 ends, run 2 begins and this 
cycle can be repeated to get uninterrupted in vivo data. If the analysis time can be 
made very short (a few seconds), such a mechanism leads to high temporal resolution. 
As discussed in the previous section, there are three mass transfer processes occurring 
in series that are associated with recovery from a microdialysis probe. The probe 
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sample analytes that are present in the extracellular matrix surrounding the probe. 
However, many times the analyte needs to diffuse from the regions farther away from 
the probe surface to the surrounding matrix in order to be sampled. For slow diffusing 
analytes, the recovery will be low, indicating that one will have to wait longer to 
obtain enough mass to get detected. In addition, diffusion of analyte can occur within 
the microdialysate due to Taylor dispersion while it is being pumped to the analysis 
system, compromising the temporal integrity of the zones and thereby diffusing zones 
of analyte that have different concentrations. Such phenomena can be mitigated by 
increasing the flow rate or reducing the length and inner diameter of the tubing.    
 
1.2.2.3. Low temporal resolution studies 
Online microdialysis systems can also be useful for studies where high 
temporal resolution is not essential.  A classic example is pharmacokinetic (PK) 
experiments in which analysis is required every few minutes over a period of hours.  
Most drugs exhibit pharmacokinetic profiles (absorption-distribution-metabolism 
excretion) that last for a few hours to several days.  Therefore, measuring the average 
concentration over a period of time (10–20 min) is sufficient for PK modeling studies.   
Another application that does not require high temporal resolution but where 
continuous online monitoring is useful is the in vitro monitoring of products of 
bioreactors.  Here, the time-course of the experiment is usually several hours or days.  
In this case, sample collection and analysis every 15 min can provide adequate 
information regarding the progress of the reaction system [42]. 
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1.2.2.4. Other considerations 
The development of a robust interface between microdialysis sampling and 
the analytical system can be challenging.  Tubing and connectors associated with 
such an interface can produce an increase in dead volume in the system that leads to a 
delayed response in online monitoring experiments as well as Taylor dispersion 
causing band broadening.  For experiments involving awake, freely moving animals, 
there is the additional dead volume associated with the swivel that connects the probe 
to the analytical system.  In extreme cases, the dialysis membrane itself can be the 
limiting factor with regard to temporal resolution [24]. 
 
1.3. Microdialysis - liquid chromatography (MD-LC) 
One of the most common separation methods used for online analysis of 
microdialysis samples is liquid chromatography (LC).  Such a system usually consists 
of LC pumps, online injector with injection loop, LC column, detector, and data 
recorder (Fig. 1.5).  The online injector is an integral part of online MD-LC systems 
as such an instrument can load and inject samples from an injection loop continuously 
without the requirement for autosamplers and fraction collectors.  Online sampling is 
usually accomplished using automated valves that reduce sample loss and make it 
possible to perform continuous monitoring.  An early report by Steele et al. employed 
multiple sample loops to continuously inject microdialysis samples without having to 
divert any sample to waste.  In this setup, no temporal information was lost by 




























Fig. 1.5: Setup of an online microdialysis-LC system (from Leggas et al. [97])  
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on the time of sample collection.  This system was well suited for pharmacokinetic 
studies [43].  Such a system can be compared to segmented flow systems discussed 
later where minimal or no sample is wasted. 
The choice of columns for online instruments has mostly been limited to 
microbore and capillary columns with internal diameters ranging form 0.5 to 2 mm, 
100–250 mm in length, and particle size 5 μm.  The primary advantage of using 
microbore columns for online systems is their ability to perform small volume sample 
analysis at low perfusion rate through the microdialysis probe. Also, because of 
smaller diameter, there is less analyte dilution, resulting in improved detection limits 
[44].   
One challenge of microbore and capillary LC separations is the need for low 
flow rate, pulse-free pumps as well as low dead volume and low dispersion 
requirements to minimize band broadening. Dead volume for microbore column 
systems can be reduced by minimizing the length and the internal diameter of all 
tubing; the flow cell for analysis also needs to have a low volume to avoid mixing and 
dispersion, all of which can increase band broadening.  The use of microbore columns 
for analysis of tirazepam and its metabolites with an improved temporal resolution of 
14 min compared to 23 min achieved with a conventional LC column was reported by 
McLaughlin et al.  [19].  Online in vivo analysis of fluconazole in blood and dermis 
was performed by Mathy et al. These investigators reported an increase of temporal 
resolution from 40 min to 24 min by using a microbore column [45].  Capillary liquid 
chromatography has also been employed with online systems employing mass 
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spectrometric (MS) detection. Capillary columns are typically 50 to 500 μm in inner 
diameter and 5 to 200 cm in length. In addition to low sample volume requirements, 
these columns produced better ionization efficiencies resulting in improved limits of 
detection for  MS [46].  
The detection method employed for online MD-LC systems is dependent on 
the analyte of interest (Table 1). UV detection has been a popular detection scheme 
for online monitoring of drugs for pharmacokinetic studies.  Electrochemical 
detection has been employed in a number of studies involving the detection of 
catecholamines and other redox active compounds of biological interest.  
Fluorescence detection (FL) has also been popular, but usually requires derivatization 
of analytes prior to analysis.  One example of online MD-LC-FL was reported by 
Yoshitake et al. in which serotonin sampled from brain was derivatized post-column 
with benzylamine in the presence of potassium hexaferrocyanate [47].   
Mass spectrometric detection has also been employed for on-line MD-LC.  
Shackman et al. used MD-LC-MS to monitor acetylcholine in vivo with limits of 
detection of 8 amol [46].  In another study, the pharmacokinetics of melatonin 
(administered i.v. in rats) was monitored over 15 hours using online microdialysis 
with LC-MS/MS [48]. 
There have been several applications of such online MD-LC systems over the 
past decade for in vivo monitoring of drugs, neurotransmitters, and other important 
biomolecules. Applications included primarily pharmacokinetic, metabolism, and 
 25
neurochemical studies.  Further information regarding the region of sampling, analyte 




Table 1.1: Microdialysis-LC 
Region of interest Analyte(s) Detection scheme 
Rat common bile duct Cefepime, moropenem, 
diclofenac 
UV [85-87] 





Rat liver Glutathione EC [93] 
Rat brain Serotonin, trazodone EC [94,95] 
Rat blood jugular vein and 
brain striatum 
Cephalexin UV [96] 
Rat brain lateral ventricle Topotecan lactone, 
carboxylate 
FL [97] 
Rat brain striatum Monoamines and their 
metabolites 
EC [44] 
Rat urinary bladder Arsenite (AsIII), arsenate 
(AsV), monomethylarsonic 
acid (MMA) and 
dimethylarsinic acid 
(DMA) 





Rat brain striatum and 
heart ventricle 
Ascorbic acid EC [36] 
Rat brain striatum Acetyl choline EC [36] 
Rat brain Rhodamine 123 FL [99] 
Rat bile duct Camptothecin FL [100] 
Rat brain striatum Serotonin FL [47] 
Rat brain and plasma EAB 515 FL [101] 
Rat brain Malondialdehyde FL [102] 
Rat brain striatum Acetyl choline MS [46] 
Rat jugular vein Melatonin MS [48] 
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1.3.1 Comments 
The narrow diameter of capillary LC (cLC) columns offers the advantage of 
high mass sensitivity, low flow rate requirements, and low consumption of sample 
and reagents that are very suitable for online microdialysate analysis [49]. The 
separation times are relatively long, which can be detrimental for designing systems 
with very high temporal resolution. In addition, the robustness of cLC columns is less 
than that of conventional LC columns, and specialized equipment is required to load 
samples to such columns, which can limit its applicability [50].  
 
1.4. Microdialysis - capillary electrophoresis (MD-CE) 
Capillary electrophoresis (CE) is particularly attractive for the analysis of 
microdialysis samples because it has very low sample volume requirements (nL to 
pL) and can perform extremely fast separations.  In CE, both the analysis speed and 
separation efficiency improve with field strength (in the absence of Joule heating). 
Therefore by using very short capillaries and high field strengths very fast, highly 
efficient separations can be accomplished.  When microdialysis sampling is 
interfaced directly to CE, it is possible to make reproducible nanoliter injections of 
sample into the CE capillary.  The electrophoretic separations range in duration from 
a few minutes to several seconds.  This makes it possible to continuously monitor 
biological processes with excellent temporal resolution.  
Laser-induced fluorescence (LIF) detection is the most popular method for 
online MD-CE, primarily because of its high sensitivity and the availability of 
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inexpensive lasers and laser-based detectors.  There are also a large number of 
reagents commercially available for fluorescence derivatization of amines, thiols, 
carbohydrates, carboxylic acids, and other functional groups.  NDA (naphthalene-2,3-
dicarboxaldehyde) and OPA (o-phthalaldehyde) are the most common reagents 
employed for the detection of amino acid neurotransmitters and other primary amines 
in vivo.  Both of these reagents are fluorogenic and exhibit fast reaction kinetics, 
making them well suited for precolumn derivatization of amino acids prior to analysis 
by CE-LIF (See Fig 1.6 for reaction scheme).  Online reaction times for OPA/β-ME 
and NDA/CN with primary amines have been reported to be 10–30 s and 120–240 s, 
respectively [51].  Table 2 summarizes experiments performed using online MD-CE.  
The relevant parameters listed include the tissue region of interest, analyte measured, 
and detection method. 
A key component of online microdialysis-CE systems is the development of 
an interface that is capable of injecting discrete nanoliter-size sample plugs from 
continuous hydrodynamic flow from the microdialysis probe (μL). The first report of 
an online MD-CE system by Hogan et al. used a nanoliter injection valve as the 
interface between the MD system and the CE separation capillary with a continuously 
running CE separation.  Perfusate from the dialysis experiment was collected in the 
nanoliter injection loop of the valve, and a special transfer line delivered the sample 
from the valve to the separation capillary inlet  The system was used to monitor 
antineoplastic agents in blood with a temporal resolution of 90 s [52].  A similar 


































































Fig. 1.6: Reaction schemes for OPA and NDA. A. Reaction of OPA with primary 
amine (RNH2) and thiol (RSH) with the key reaction intermediates. B. Reaction of 
NDA with primary amine CN- that produces fluorescent CBI derivative. (from De 
Montigny et. al. [108]) 
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aspartate and glutamate release in the brain [53].  Later, the transdermal delivery of 
nicotine was monitored using on an online microdialysis-capillary electrophoresis 
system with electrochemical detection [54]. The system incorporated a carbon fiber 
working electrode and a cellulose acetate decoupler before the separation capillary to 
shield the animal from high voltage. The cutaneous nicotine concentration was 
monitored for 24 hours following application of a Nicotrol patch. The temporal 
resolution was 10 min.   
Lada et al. used a flow-gated interface instead of a valve to inject 
microdialysis samples into the separation capillary.  This interface made it possible to 
perfuse the microdialysis probe at submicroliter/min flow rates and still obtain 
temporal resolutions of 65–85 s [55].  Subsequently, the same group demonstrated 
extremely fast separations of glutamate and aspartate using a short capillary (6.5 cm) 
with a temporal resolution of 12 s [24].  A similar system was utilized to separate and 
perform quantitative analysis of multiple neurotransmitters in the brain (45 s temporal 
resolution) using micellar electrokinetic chromatography (MEKC) [56].  A system 
designed with a sheath-flow cuvette for improved sensitivity (15-fold) (by reducing 
background fluorescence and laser scattering) was reported by Bowser et al. [57]. The 
separation capillary (10 mm ID, 150 mm OD) outlet was connected to a quartz 
cuvette (outer dimension 2 mm x 2 mm sq.; inner dimension 2 μm x 2 μm sq) and 
sheath buffer flow was maintained outside the capillary by a siphoning effect that 
resulted in laminar flow profile of the analytes leaving the capillary.  This system was 
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used to monitor amino acids in the brain of a freely moving animal. Seventeen amino 
acids were separated in 30 s following precolumn derivatization with NDA [51].   
The most popular application of online MD-CE systems in vivo has been 
measuring amino acid neurotransmitters in the brain.  In general, the change in 
concentration from basal is measured following an external stimulus.  In most cases, a 
drug or other substance is added to the perfusate to evoke the response.  A common 
experiment is that of high potassium stimulation, which causes the release of 
excitatory amino acids into the extracellular fluid [53,56-59]. An electropherogram 
produced from such an experiment is shown in Fig. 1.7. The glutamate reuptake 
inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC) has also been administered 
via the microdialysis probe for monitoring glutamate and aspartate [24,60].  Other 
experiments include monitoring changes in ascorbic acid following subcutaneous 
injection of amphetamine [55], monitoring brain amino acids following 
intraperitoneal injections of saline (0.9% v/v) and ethanol (20% v/v) [51], and 
monitoring dopamine in the brain following injection of cocaine [61].  
 
1.4.1. Comments 
 Compared to capillary LC, capillary electrophoresis can produce very fast 
analysis times due to application of high field strengths (30 kV). Therefore, high 
temporal resolution can be attained for on-line systems.  The major drawback of on-
line systems using fused silica capillaries is the need for connecting tubing between 


































Fig. 1.7: Change in concentration of amino acids following potassium ion 
stimulation. A. Basal. B. After K+ stimulation. (Bowser et al. [57]) 
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band broadening and loss of temporal resolution. This is particularly the case with 
awake animal systems that use liquid swivels.  For extremely fast separations, very 
short capillaries are employed at high field strengths.  In humid environments, arcing 
can be a problem. Lastly, the on-line systems using conventional capillary 
electrophoresis are relatively large and do not lend themselves to the development of 
on-animal analysis systems.  In contrast, the microchip systems (next section) have 
the potential to be completely miniaturized for use in on-animal sensing.  
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Table 1.2: Microdialysis – CE 
Region of interest Analyte(s) Detection scheme 
Rat brain striatum 
 
Glucose, lactate EC [84] 
Rat brain striatum 
 
Dopamine FL [61] 




Rat brain striatum 
 
D-serine FL [104] 






Larval tiger salamander 
retina 
 
D,L-serine FL [106] 




Rat dermis  Nicotine 
 
EC [54] 
Rat brain striatum O-phosphoethanolamine, 
excitatory amino acid  
 
FL [60] 
Rat brain striatum Glutamate and aspartate 
 
FL [24] 
Rat caudate nucleus Glutathione and cysteine 
 
FL [59] 
Rat caudate nucleus Primary amines 
 
FL [56] 
Rat caudate nucleus Ascorbate 
 
UV [58] 
Rat brain hippocampus Glutamate and aspartate 
 
FL [53] 
Rat vein (opposite to 
jugular vein) 
 
Antineoplastic agent FL [52] 
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1.5. Microdialysis - microchip electrophoresis (MD-MC) 
More recently, microchip electrophoresis has become an attractive analytical 
platform for the online analysis of microdialysis samples.  Microchips have several 
advantages for online analysis of microdialysis samples.  These include the ability to 
manipulate samples on-chip using a combination of electroosmotic and 
hydrodynamic flow, integrated sample preparation or derivatization, nL to pL sample 
volume requirements, fast analysis times, and the ability to integrate the detector 
directly into the chip.  Most of the research in this area has exploited one or both of 
the two major advantages of microchip-based devices.  The first is the ability to 
perform very fast separations on-chip for monitoring fast biochemical processes.  The 
second is miniaturization of the system for on-animal sensing.  
Most of the work over the past several years has been focused on the 
development of interfaces between the microdialysis sampling system and the 
microchip electrophoresis system.  The major challenge has been to develop an 
interface that can inject nL to pL volume samples continuously and reproducibly into 
the electrophoresis channel while still achieving adequate temporal resolution 
(frequency of injecting and analyzing samples) for the experiment of interest.  Other 
challenges include interfacing the external tubing used for microdialysis sampling 
with analysis chip.  In addition, fast and efficient derivatization strategies must be 
incorporated online for detection of amino acid neurotransmitters and peptides.  
Microdialysis sampling coupled to microchip electrophoresis for online 
analysis was first reported by Huynh et al. [62].  The microchip device was fabricated 
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from soda-lime glass and consisted of a twin T channel (Fig. 1.8A).  A continuous 
stream of perfusate was delivered to the microchip using a syringe pump that 
continuously perfused the cylindrical 4 mm CMA/12 microdialysis probe with 20 
mM boric acid buffer.  A commercially available microtight union (Upchurch 
Scientific) was used to connect the PEEK tubing from the microdialysis sampling 
system to the electrophoresis chip.  Injection was accomplished using a gated voltage 
that cut off the hydrodynamic flow at the injection cross, allowing introduction of a 
plug of sample into the separation channel for analysis.  Such an injection scheme 
made it possible to continuously inject discrete plugs of microdialysis sample into the 
separation channel for fast electrophoretic separation of analyte.  The system was 
used to successfully monitor the activity of the enzyme β-galactosidase.  This enzyme 
catalyzes the hydrolysis of fluorescein mono-β-galactoside (FMG) to produce 
fluorescein.  Both the substrate and the product were monitored using the online 
system with LIF detection (Fig. 1.8B).  The lag time (time needed for the device to 
respond to a concentration change) on this device was 5–7 min.   
A similar setup was employed for online sampling, derivatization, and 
detection of an in vitro mixture of amino acids and peptides [63].  On-chip labeling of 
analytes was accomplished using NDA and 2-mercaptoethanol (2ME).  The NDA and 
2ME were dissolved in 20 mM borate buffer and were added to the run buffer 
reservoir.  Following a gated injection scheme, the plug of sample reacted with the 
derivatization reagent at the beginning of the electrophoretic separation.  The analytes 
were separated and detected with a temporal resolution of 30–40 s.  
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Kennedy’s group employed a gated injection scheme to continuously monitor 
in vivo amino acid neurotransmitters using a microdialysis microchip setup with an 
effective temporal resolution of 2–4 min [64].  The chip device was fabricated from 
borosilicate glass (Fig. 1.9A).  Reaction channels were incorporated for the 
derivatization of the sample collected via a side-by-side microdialysis probe 
(fabricated in-house) implanted in the brain of an anesthetized rat.  The precolumn 
reaction was achieved by mixing OPA and 2ME with the stream of microdialysate 
(Fig. 1.9B).  Following the reaction, a gated injection scheme introduced plugs of 
sample into the separation channel for analysis by LIF.  The interface in this device 
consisted of capillary tubing from the probe outlet connected to the chip via an 
Upchurch fitting.  
A similar approach was employed by Cellar et al. for low-flow, push-pull-
based microdialysis sampling.  This system also employed online derivatization 
followed by injection into a short fused silica CE capillary for separation and LIF 
detection [65].  The chip incorporated a number of valves fabricated using a 
multilayer soft lithography technique and actuated by nitrogen gas pressure controlled 
by solenoid valves.  In this and the previous study, changes in concentration of the 
endogenous amino acid neurotransmitter (glutamate) were monitored following 
perfusion with high potassium.  The effect of administration of the glutamate 
reuptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC) through the 








































Fig. 1.8: Online in vitro microdialysis microchip. A. Chip design and setup. B. In 


































Fig. 1.9: Online in vivo microdialysis microchip. A. Chip design. B. Microdialysis 
sample analysis (marked peak is glutamate). (From Sandlin et al. [64]) 
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The use of a solenoid-controlled pneumatic valving method for sample 
injection in an online microdialysis microchip system has been described by the 
Martin group [41, 66]. The general design (Fig. 1.10) consists of one or two nitrogen-
actuated PDMS microvalves that are used to inject or manipulate the flow of fluid 
within the chip.  The CE separation channel is situated at a right angle to the flow 
channels.  Sample injection was achieved by actuation of the valve at the flow 
channel/separation channel junction and was followed by electrophoresis with LIF or 
electrochemical detection.  
In the first report Li et al. used this approach for continuous injection and 
separation of fluorescein and dichlorofluorescein with temporal resolution of 20 s 
[66].  All fluids were delivered from the syringe pump or from the probe using a 
capillary.  The lag and rise times (time needed for the response to change from 10% 
to 90% of the total change) were reported to be approximately 6 min and 2 min, 
respectively.  More recently, amperometric detection has been incorporated into the 
system by Mecker et al.  In this study, the stimulated release of dopamine from PC12 
cells cultured in a Petri dish was monitored using a 5 mm cylindrical microdialysis 
probe placed over the cells.  In this case, the lag time was approximately 5 min and 
the rise time was 2 min [41]. 
The use of segmented flow to create reaction chambers for derivatization has 
also been investigated for online microdialysis-microchip electrophoresis.  Wang et 
al. developed a system in which aqueous sample plugs were created in a stream of oil 
(perfluorodecalin) [67].  The frequency and size of the droplets were dependent on 
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Fig. 1.10: PDMS microchips with pneumatic valving. A. Chip with 2 valves (1 and 2). 
B, BW and SW are buffer, buffer waste and sample waste, respectively. NO and NC 
refer to valves that are “normally open” and “normally closed,” respectively. B. 
Online detection of dopamine from PC 12 cells. (From Mecker et al. [41]) 
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the relative perfusion rates of oil and water from the respective syringe pumps (Fig. 
1.11A).  The plug of aqueous sample was interrogated at the end of a 7-cm-long 
capillary connected to the chip.  With this system, glucose was measured online using 
glucose oxidase and Amplex Red (Fig. 1.11B).  The same reaction scheme was 
employed for monitoring extracellular glucose in rat brain by microdialysis sampling; 
a change in glucose concentration in the brain was brought about by perfusion of 100 
mM potassium through the probe.  
This interface has also been employed to perform electrophoretic separations 
from a continuous segmented flow, which can potentially be used for CE separation 
of microdialysis samples [68].  In this case, the chip consisted of a flow channel (75 
μm deep and 250 μm wide) and an electrophoresis channel (7.5 μm deep and 20 μm 
wide) that were thermally bonded with a K-shaped interface overlap for sample 
injection (Fig. 1.12A).  Aqueous plugs were generated between the oil phase 
(perfluorodecalin) segments based on optimization studies reported previously by the 
Ismagilov group [69].  
For injection of discrete plugs for CE separation, two modes of injection were 
described.  For the “discrete injector,” a series of sample plugs were injected; the 
injection volume was dependent on the electrophoresis field strength and temporal 
width of the plug.  For the “desegmenting injector,” the sample plugs coalesce at the 
K junction from which electrokinetic injections can be made repeatedly for analysis. 
Primary amines were derivatized on-chip with NDA/CN and then analyzed using the 


































Fig. 1.11: Segmented flow for flow-through analysis. A. Setup  B. LIF response for 
glucose after reaction with glucose oxadase (GOX)/horseradish peroxidase (HRP) 
and Amplex Red to produce fluorescent Resorufin. The concentration of glucose was 
changed at the probe from 0.2 mm to 1 mm. (From Wang et al. [67]) 
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performed with the amino acids in which the change in concentration from 1 μM to 
blank solution was registered on chip in 20 s (Fig. 1.12B).  These methods offer a 




The development of online microchip-based systems is ideal for studies 
requiring high temporal resolution. However, there can be several challenges 
associated with building such devices. First, the separation must be optimized and 
careful consideration needs to be given to the separation and identification of the 
analyte(s) of interest in the matrix being sampled.  Interfacing the electrophoretic 
separation with the hydrodynamic flow can be a long, drawn-out process in which 
extensive investigation is required to determine the optimal microchannel design and  
dimensions for the specific application. For example, setting up repeated injections 
from a continuous flow of microdialysate can be challenging in a gated injection 
scheme. Second, fabricating glass-based chips can be challenging in many lab 
facilities as it involves a high temperature thermal bonding step that can yield poor 
success rates. Glass microchips are commercially available for such applications but, 
for many labs, are cost prohibitive. Although PDMS microchip devices are easy to 
fabricate they suffer from analyte adsorption and changing EOF. Several complex 


































Fig. 1.12: Glass microchip for segmented flow and electrophoretic separation. 
A. Design B. Amino acid analysis after derivatization with NDA/CN. (From Roman 








and maintain the EOF for a longer period of time on such devices [70]. Third, the 
performance of the chip is dependent on a number of factors such as removal of waste 
(reduce hydrostatic pressure) and frequent replenishment of buffer; integrating such 
steps on chip may require a fair degree of automation. Lastly, much of the equipment 
used for such systems must be custom built or is lab specific (e.g., software, power 
supplies). Therefore, a wide variety of technical resources and expertise needs to be 
available for developing these systems.  
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Table 1.3: Microdialysis – microchip electrophoresis 
Region of interest Analyte(s) Detection scheme 
In-vitro enzyme assay Conversion of FMG to 
fluorescein by β-gal 
 
LIF [62] 
Rat brain striatum Glutamate 
 
LIF [64] 




GABA, serine, glycine 
 
LIF [63,66] [68] 
In vitro analysis (PC12 
cell) 
 





1.6. Microdialysis coupled to biosensors 
Biosensors are analytical devices with a biological recognition element that 
produce an electrical signal in response to a biological change. An ideal biosensor 
should be able to perform continuous and reliable monitoring of analyte from 
complex body fluids of patients over a significant period of time.  There are many 
types of biosensors. Many are enzyme-based and employ either electrochemical or 
optical detection. Online microdialysis-biosensor systems should be able to handle 
low sample volumes (microliter) if high temporal resolution is required.  Also, such 
systems should ideally exhibit high sensitivity and specificity for the analyte(s) of 
interest in the presence of other endogenous electroactive analytes [71]. A flow-
through biosensor has been reported for direct coupling to continuous low-flow 
microdialysis.  Analyte selectivity for glucose and lactate was achieved in this device 
using immobilized oxidoreductase enzymes followed by amperometric detection of 
hydrogen peroxide [72]. 
Online microdialysis sampling coupled to biosensors has been reported for 
analytes such as ascorbate [73], glucose, lactate [74,75] and glutamate [74,76,77]. 
The simultaneous monitoring of glucose and lactate in rats under hypoxic conditions 
was reported by Jones et al. [78]. Yao et al. also reported an online system for  
multianalyte in vivo monitoring.  The biosensor consisted of a triple enzyme electrode 
that selectively detected glucose, l-lactate, and pyruvate without significant cross-
reactivity [79].  Similar flow injection-based online systems were described by the 
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same group for L-glutamate, acetylcholine and dopamine [80] and D-/L-lactic acid  
[81].  
Gramsbergen et al. developed an online system for glucose and lactate to 
monitor ischemic events in freely moving rats.  The analytes were monitored by flow 
injection analysis with enzyme-based amperometric detection [82]. The development 
of a flow-through sensor with chemiluminescence detection for glucose monitoring in 
an awake rabbit has also been described [83]. Recently, online monitoring of glucose 
and lactate from rat brain was performed following ischemia and reperfusion. The 
sensor employed methylene green adsorbed on single-walled carbon nanotubes for 
detection [84].    
 
1.6.1 Comments 
Biosensors can yield good temporal resolution since no separation step is 
required. However, most biosensors are developed for a single analyte, so it is not 
possible to analyze several compounds of a similar class (catecholamines, amino 
acids) simultaneously as it is with separation-based sensors. Microdialysis does have 
an advantage over placing the sensor directly into the tissue of interest in that the 
probe membrane will eliminate fouling and an immune response that could be 
generated by sensor implantation. In addition, sensor arrays have been found to be 




Table 1.4: Microdialysis – biosensor 
Region of interest Analyte(s) Detection scheme 




Rat subcutaneous tissue 
 
Glucose, lactate EC [75] 
Rat cortex  
 
Glucose, lactate EC [78] 
Frontal lobe of rat brain Glucose, l-lactate, 






Glucose Chemiluminescence [83] 
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1.7. Concluding remarks 
 Microdialysis is a well established sampling technique that has found 
application in many areas, most notably in monitoring biological compounds in vivo.  
Advances in fabrication technologies have led to the development of innovative 
microchip technologies suitable for real-world monitoring applications.  
Microdialysis/microchip systems offer several advantages, including lower cost, 
faster analysis for improved temporal resolution, and simplified connections and 
fittings for device fabrication and operation.  While the performance of conventional 
bench-top systems is currently superior to that of the separation-based devices, initial 
reports clearly demonstrate the potential of coupling microdialysis to microchip 
platforms.   
 Future developments will see the optimization of device design and the 
investigation of alternative materials for microchip, electrode, and membrane 
fabrication.  It is envisioned that further advances in fabrication and integration 
procedures will allow the development of implantable/wearable 
microdialysis/microchip systems for personal or on-animal monitoring.  Integration of 
the separation-based systems with powerful detection techniques such as mass 
spectrometry will further improve the detection capability of these systems for 
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 Microdialysis is a continuous sampling technique widely implemented for the 
measurement of neuroactive compounds in the central nervous system (CNS) 
extracellular space. This technique has been applied to a variety of research areas 
including pharmacokinetics [1-3], neuroscience [4,5] and biotechnology [6].  
Microdialysis has been used to sample a variety of neurochemically important 
compounds including amino acids (aspartate, glutamate) [7-9], 5-hydroxytryptamine 
(5-HT) [10], catecholamines (dopamine, norepinephrine, epinephrine) [11-13], and 
their metabolites (3,4-dihydroxyphenylacetic acid, homovanillic acid, dopamine 
glucuronide) [14-17] and neuropeptides (angiotension 1, methionine enkephalin, and 
neurotensin) [18-23].  
 For online microdialysis systems, CE is a very attractive mode for separation-
based analysis; this is attributed to the fact that small volumes (nL) of sample can be 
quickly injected in CE systems from the uninterrupted microdialysate flow stream 
along with the easy integration of highly sensitive laser induced fluorescence (LIF) 
detection. For similar reasons, microchip electrophoresis can be an even better 
alternative to CE as the channel dimensions in microchips are typically shorter and 
narrower than CE channels and therefore sample volume requirements are smaller 
(pL) and the high field strengths lead to extremely fast analysis times (less than 2 
minutes). Also, microchip electrophoresis has a small footprint and can be custom 
built based on the application with the incorporation of commercially available 
interfacing products for hydrodynamic flow. In addition, fluorescence detection can 
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be easily employed for such devices (glass and PDMS). PDMS is very popular 
material for such devices because of their low cost and their optical transparency at 
wavelengths as low as 280 nm with a refractive index of 1.43 [24]. Also, PDMS 
microchips are easier to fabricate compared to glass.  
 The first coupling of online microdialysis with microchip electrophoresis was 
reported by our group in 2004 [25]. The online system facilitated delivery of 
microdialysis sample to a twin-t chip where sample was continuously injected by 
gated injection and analyzed. The conversion of fluorescein mono-β-d 
galactopyranoside (FMG) to fluorescein by the enzyme β-galactosidase was 
monitored using this device. The reaction was carried out in vitro in an off-chip vial 
and sampled by microdialysis. However, in order to use such systems for the analysis 
of real world samples, incorporation of derivatization and alternative detection 
methods are absolutely necessary.  For many in vivo monitoring applications, 
derivatization of analytes with a fluorophore must be accomplished either off-chip or 
on-chip for high sensitivity fluorescence detection. 
 Derivatization strategies have been reported in microchip devices using 
precolumn [26-31] and postcolumn reactors [32-34].  The microchip platform is 
particularly attractive for incorporating derivatization because of integration of 
reaction channels with virtually zero dead volumes and short mass transport times 
[35]. The sample can be derivatized prior to injection and separation using a 
“precolumn” reactor; alternatively, the analyte can be derivatized in a “postcolumn” 
reactor after separation. In postcolumn reactors, the derivatization reagents should be 
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introduced into the separation channel prior to the electrophoresis ground; therefore 
in the true sense it is actually an “on-column” reaction. However, this is referred to as 
“postcolumn” derivatization as the reaction occurs close to the detector [35].  
For the rapid derivatization of analytes containing primary amines (e.g. amino acids 
and peptides), ortho-phthalaldehyde/2-mercaptoethanol (OPA/2-ME) has been a 
popular choice for on-chip derivatization [26,32]. However, OPA derivatives are 
quite unstable as the isoindole derivatives exhibit a time-dependent degradation. It 
can therefore sometimes be tricky to optimize precolumn OPA/RSH because the 
product can degrade before injection leading to irreproducible results. This could be 
particularly be a problem if multiple analytes with different optimum derivatization 
times need to be analyzed.  
 An analog of OPA that exhibits very similar reaction chemistry with primary 
amines is naphthalene-2,3-dicarboxaldehyde (NDA); derivatization products of NDA 
have been found to be more stable than those of OPA particularly in the case of 
peptides with CN- as the nucleophile [36].  It has been shown that replacement of 
cyanide (CN) with a thiol increases the reaction rate, making NDA/2ME more 
suitable for on-column and postcolumn derivatization.  NDA/2ME has been 
employed for rapid amino acid and peptide analysis following liquid chromatography 
[37,38] and capillary electrophoresis [39].  NDA was also employed for on-column 
derivatization of reduced glutathione on a microchip electrophoresis device [40]. 
Strategies with LIF detection has also been reported with other derivatizing agents 
[30,41]. 
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 The present study aims to evaluate the application of NDA/2ME for the on-
column derivatization of amino acids and peptides by microchip electrophoresis. The 
reagents (NDA/2-ME) were incorporated into the background electrolyte. 
Theoretically, such an approach should lead to simultaneous separation and 
derivatization of analytes of analytes (if the reaction occurs very fast) before being 
detected. The devices used for these studies described in this paper consist of a glass 
layer containing etched microfluidic channels that was plasma sealed with a layer of 
poly(dimethylsiloxane) (PDMS) [42].  This fabrication approach was a quick and 
easy alternative to the production of similar devices reported by our laboratory that 
were composed exclusively of glass [25].  Specifically, the hybrid device precludes 
the very time-consuming and delicate high-temperature bonding process that is 
necessary to produce glass microchip devices.  The hybrid glass-PDMS devices 
constructed here are easily sealed and can also be taken apart and re-sealed in the 
event of a channel blockage.   
 In these studies, hybrid microchip electrophoresis devices were constructed 
for continuous on-line sampling from a syringe pump or microdialysis.  The 
combination of this device with dynamic on-column sample derivatization using 
NDA/2ME was evaluated for peptide and amino acid analysis.  Such work 
demonstrates the integration of on-chip sample derivatization into an already highly-
integrated device.  This separation-based sensor can ultimately be employed for high-
temporal resolution monitoring of primary amines of biological significance.  
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2.2. Materials and Methods 
  Materials and reagents: All chemicals and materials were used as received:  
boric acid, sodium hydroxide, 2-mercaptoethanol, amino acids, and peptides were 
purchased from Sigma (St. Louis, MO).  Hydrochloric acid, sulfuric acid, 30% 
hydrogen peroxide, ammonium hydroxide, acetone, and isopropyl alcohol were from 
Fisher Scientific (Fair Lawn, NJ).  Naphthalene 2,3-dicarboxaldehyde (NDA) was 
purchased from Bioanalytical Systems (BAS, West Lafayette, IN).  PEEK tubing 
(250 µm i.d., 510 µm o.d.), tubing fittings, and low dead-volume unions were 
obtained from Upchurch Scientific (Oak Harbor, WA).  Soda lime glass with pre-
deposited layers of chrome and positive photoresist were purchased from Telic (Santa 
Monica, CA).  Sylgard 184 with curing agent was from Ellsworth Adhesives 
(Germantown, WI).  Positive photoresist developer was from Clarion (Sommerville, 
NJ) and chrome stripper was from Cyantek Corp. (Fremont, CA).  Buffered oxide 
etchant containing 10% hydrofluoric acid was from Fox Scientific (Alvarado, TX).   
 
  Construction of the microchip devices: Microchip devices were fabricated in-
house using standard photolithographic techniques.  The microchip design was drawn 
using Microsoft Freehand 8.0 software and then a negative mask transparency was 
produced.  For the production of the glass layer containing the separation channel 
[25], the negative mask transparency was placed on top of a piece of soda lime glass 
with predeposited layers of chrome and AZ1500 photoresist.  The glass was exposed 
 75
to UV light for 15 s and then placed in AZ developer, rinsed with Nanopure water, 
and baked at 95°C for 10 min.  The exposed layer of chrome was then removed using 
chrome stripper.  A temperature-controlled circulating etch bath (Modutek, San Jose, 
CA) of buffered oxide etchant was used to etch the channels in the glass. The total 
etching time was 40 min. The glass was removed from the bath intermittently and 
dipped into a solution of 1 M hydrochloric acid, rinsed with water, and dried with a 
filtered stream of N2 gas to minimize the particulate buildup in the channels.  Once 
the etching was complete, the protective photoresist and chrome layers were removed 
using acetone and chrome stripper, respectively. 
 The etch profiles were measured using a Tencor Alpha Step 200 profilometer 
(San Jose, CA); the channel dimensions were found to be 90 μm wide at the top of the 
channel and 35 μm wide at the bottom of the channel with a depth of 20 μm.  For the 
wider sampling channel, the width was 500 μm and the depth was 20 μm.  Channel 
lengths for all microchips were as follows (see Figure 2.1A): the sampling channel 
was 23 mm; the segment connecting the sampling channel to the injection t was 7 
mm; the arms connecting the injection t to the buffer and buffer waste reservoirs were 
both 10 mm; the separation channel was 25 mm total with fluorescence detection 
carried out 20 mm downstream from the injection t. 
 Access holes were drilled into the glass layer and the fluidic connector  was 
adhered to the glass layer using J.B. Weld (Sulfur Springs, TX).  The fluidic 
connector was modified from a low dead-volume union (nanoport, Upchurch 
Scientific, Oak Harbor, WA) (Figure 2.1B).  To produce the PDMS layer, a 7:1 (w/w) 
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mixture of Sylgard 184 and curing agent mixture was poured onto a silicon wafer and 
allowed to bake in an oven at 70°C for at least 3 h.  The layer was then carefully 
peeled off of the wafer master and used to plasma-seal the glass layer.  Both the glass 
and PDMS layers were placed into a plasma oxidizer (Harrick Scientific, Ithaca, NY) 
for 90 s and put in contact with one another immediately to complete construction of 
the device.  The flexible PDMS layer could easily be removed using a razor blade to 
allow the glass layer to be cleaned and re-sealed in the case of blockages.  
 
  Device coupling to syringe and microdialysis sampling: The syringes, syringe 
pumps, probes, and Teflon tubing (0.65 mm o.d. × 0.12 mm i.d.) used for the 
experimental setup were obtained from Bioanalytical Systems. The general setup for 
these experiments has been described previously [25] and a schematic representation 
is shown in Figure 2.1C.  Briefly, the modified nanoports (Figure 2.1B) were cut in 
half using a dremel tool (Ace Hardware, Lawrence, KS) and adhered to the devices as 
described above.  Tubing could then be inserted into a male fitting and easily screwed 
into the nanoport attached to the microchip.  This setup served as a fluidic connection 
to the microchip, and the other end of the tubing was connected to either a syringe or 
microdialysis probe.  A flow rate of 1.0 μl/min was used in the experiments.  
Microdialysis probes received from the manufacturer (BR-4, 4mm cylindrical probe, 
BAS, West Lafayette, IN) were packaged with a plastic protective cap; this cap was 
cut using a razor blade to expose the probe tip (Figure 2.1B).  This fixture could then 
be easily slotted into a 1.5 ml Eppendorf tube (Fisher Scientific) that contained 
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sample.  The perfusion syringe, filled with boric acid buffer, was connected to the 
inlet of the 4-mm microdialysis brain probe (BAS).   
 
  Device operation conditions: A solution of 25 mM boric acid buffer adjusted 
to pH 9.2 with 1 N NaOH was used as the electrophoresis buffer.  The device was 
conditioned by flushing the microchip with 0.1 N NaOH for 15 min prior to filling 
with boric acid buffer.  Platinum electrodes were inserted into the reservoirs of the 
microchip and a voltage of 2300 V was applied to the buffer reservoir (B) while 
keeping the buffer waste (BW) and sample waste (SW) reservoirs at ground (Figure 
2.1A).  Voltages were applied using a four-channel bipolar high voltage system 
(Jenway, Essex, England, UK) that was controlled by a Toshiba laptop computer.  
During device operation, the voltage was applied continuously to electroosmotically 
prevent sample leakage into the separation channel of the microchip.  When the 
voltage was turned off (1 s), the injection t was filled with sample and reapplication 
of voltage allowed a small plug to be injected down the separation channel [25,43].  
 For derivatization experiments, stock solutions of 10 mM NDA and 60 mM 
2ME were prepared in methanol and in a 1:1 solution of methanol and run buffer, 
respectively.  The following stock solutions of amino acids and peptides were 




Fig. 2.1:  A) Picture of PDMS-glass hybrid device used in initial studies.  Device is 
constructed by etching channels into the glass layer and irreversibly sealing with a 
layer of PDMS.  Reservoirs:  B = buffer, SW = sample waste, BW = buffer waste.  
Derivatization reagents were added into the buffer reservoir.  B) Inlet sample port was 
modified from a high-pressure union, into which a male fitting could be fastened.  
Also shown is a microdialysis brain probe with modified cap that could be slotted into 
a vial for in vitro sampling.  C) Schematic of the setup for microdialysis sampling to 
the microchip.  
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leucine enkephalin, 50 mM Gly-Pro, and 50 mM Arg.  Sample mixtures were 
prepared in buffer from the stock solutions and used to fill a syringe for direct 
sampling or placed into a vial for on-line microdialysis.  A derivatization mixture of 
0.6 mM NDA/1.2 mM 2ME in buffer was placed in the buffer reservoir of the device.  
This derivatization mixture was determined to be optimum for device operation as it 
was the maximum concentration of agents that could be placed in the buffer reservoir 
while still maintaining proper injection gating.  This determination was carried out by 
hydrodynamically pumping a syringe of 200 μM disodium fluorescein at 1.0 μl/min 
and imaging the injector t using an Axioskop fluorescence microscope (Zeiss USA, 
Thornwood, NY) with different mixtures of various NDA/2ME concentrations (data 
not shown).  The experiments were carried out under device operating conditions of 
2000 V applied voltage and an injection time of 1 s.    
  
  LIF detection: A home-built LIF detection setup similar to that previously 
described was employed [25].  Briefly, laser light was directed into an optics cube 
using three mirrors (Thor Labs, Newton, NJ).  The optics cube contained a dichroic 
mirror that directed the beam 90 degrees into a long working distance objective (N.A. 
= 0.6, 40X LWD Plan Fluorite LCP LFL; Olympus America, Melville, NY), which 
was translatable in the X-Y planes.  This objective focused the beam to a spot onto 
the separation channel of the microchip, which was secured on a X-Y-Z translatable 
stage.  Fluorescence was collected with the same microscope objective, passed 
through the dichroic mirror, and reflected 90 degrees with a mirror toward a R1477 
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photomultiplier tube (Hamamatsu, Bridgewater, NJ) contained in a tube housing 
(Thermo Oriel, Stratford, CT).  Appropriate excitation and emission spectral 
filtering were used to decrease background.  However, spatial filtering with a pinhole 
was not used in this setup.  The 442-nm line of a HeCd laser (Kimmon, Englewood, 
CA) with 450DRLP dichroic was employed for the experiments.  Analogue signal 
filtering was accomplished with the use of a Standford Research Systems pre-
amplifier (Sunnyvale, CA) and converted into digital output using a DA-5 unit from 
BAS.   
 
2.3. Results and Discussion 
2.3.1. Hybrid microchip device 
 A hybrid microchip device was employed for the studies described in this 
paper.  Plasma sealing of a PDMS layer to a glass layer containing etched fluidic 
channels is much easier for device fabrication compared to high-temperature glass 
bonding of two glass plates.  By using the PDMS sealing method, devices were 
quickly and easily assembled for use.  In cases where channel blockages were 
observed, the PDMS layer of the device could be removed with a razor blade and the 
glass layer cleaned for re-use.  In this case, the channels are composed of three walls 
of glass and one wall of PDMS.  The presence of PDMS in the channel can have an 
effect on the electroosmotic flow as well as providing some sites with potential for 
interactions with hydrophobic analytes.  However, in our application, we did not 
observe any problems associated with hydrophobic interactions such as peak tailing 
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or band broadening.  A more thorough investigation involving a direct comparison of 
the hybrid and all-glass chips would better elucidate how the PDMS layer affects 
device operation and performance; however, such work is beyond the scope of these 
studies.   
 
2.3.2. On-chip sample derivatization of peptides and amino acids using 
NDA/2ME 
 A microdialysis-microchip device based on a similar design in glass was 
characterized previously for optimal microdialysis sample flow, voltage application 
scheme and injection time [25].  To increase the utility of this system for the detection 
of non-fluorescent samples of biological interest such as peptides and amino acids, a 
derivatization scheme was incorporated into the chip.  The primary amine groups of 
amino acids and peptides were the target for the derivatization chemistry using 
naphthalene-2,3-carboxaldehyde/2-mercaptoethanol.  Initially, a solution of 1 mM 
Glu was pumped into the device and reacted with a mixture of 0.6 mM NDA/1.2 mM 
2ME in the buffer reservoir.  Under these conditions, individual injection plugs of 
Glu were detected in less than 20 sec using LIF detection (data not shown) at an 
excitation wavelength of 442 nm.  Concentrations of less than 1 mM of this and other 
amino acids examined resulted in no detectable peaks under the conditions employed.   
Next, a simple mixture of two amino acids, 5 mM Phe and Glu, was pumped into the 
device under the same conditions as described above, and sequential injections were 
carried out.  Figure 2.2 shows repeated injections (30 secs interval) of mutiple amino 
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acids that were baseline-resolved with good reproducibility (RSD = 4.3% and 4.5% 
for Phe and Glu, respectively; n = 6).  The migration times of the analytes can be 
viewed as the amount of time the analytes had to react with the derivatization agents.  
This was estimated to be 12 and 18 s for Phe and Glu, respectively.  Separations of 
simple mixtures of peptides and amino acids introduced from a syringe were also 
evaluated using this system.  These mixtures, which consisted of A) L-enkephalin and 
Asp and B) Gly-Pro and Glu, were analyzed and the results are shown in Figure 2.3.  
The concentrations of analytes in their respective mixtures were 5 mM.  In these 
experiments, simultaneous separation and reaction of the analytes was accomplished 
in less than 20 s.    
 On-chip derivatization with simultaneous separation has been conducted for 
proteins and peptides in a microchip capillary gel electrophoresis format by Landers 
and coworkers [44,45].  In these studies, the investigators used NanoOrange, a 
commercially available dye, as a non-covalent fluorescent binding agent for protein-
SDS complexes.  Long separation channel lengths (75 mm) were employed to allow 
greater product yield and, thereby, decrease limits of detection but at the cost of 
longer analysis times (300 s).   
 Estimated injection plug lengths of 20 μm correspond to approximately 12 
fmol injected of 5 mM amino acid and peptide samples.  In comparing the present 
studies to earlier work utilizing precolumn OPA/2ME derivatization on microchip 












Fig. 2.2:  Sequential injections and separations of 5 mM concentrations Phe and Glu, 
derivatized on-chip with a mixture of 0.6 mM NDA and 1.2 mM 2ME.  Conditions 
were as follows: applied voltage of 2300 V was used with a 1 s sample fill time and a 











Fig. 2.3:  Amino acid and peptide separations.  Amino acids and peptides were 
derivatized on-chip using NDA/2ME.  Consecutive injections of A) Leu-enkephalin 
and Asp and B) Gly-Pro and Glu.  Conditions were similar to those used in Figure 2.    
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were reported by Jacobson et al. [26].  More recently, Kennedy’s group used this 
approach for precolumn derivatization of Arg, Glu, and Asp with OPA/2ME using 
on-line microdialysis/microchip electrophoresis. Their detection limits were 0.13, 
0.08, and 0.09 fmol for Arg, Glu and Asp, respectively [46].  For postcolumn 
derivatization, detection limits were 200, 130, and 120 fmol for Arg, Gly, and Thr, 
respectively [32].  The limits of detection (LOD) for this work employing on-column 
derivatization were better than those reported for a postcolumn scheme; however, 
precolumn derivatization limits of detection were 2–3 orders of magnitude lower than 
the LOD demonstrated here.   
 Future improvements to the current design can be made by increasing device 
channel length for on-column derivatization or the investigation of precolumn 
derivatization to ensure complete reaction of reagents and analytes.  Employing a 
pinhole filter in the LIF detection setup to reduce scattered light and fluorescence 
background could also be considered to improve detector sensitivity.  In addition, 
further optimization of buffer conditions and the use of cyclodextrin modifiers to 
reduce any background and increase fluorescence, respectively, can be carried out 
[47].    
 
2.3.3. On-line microdialysis sampling with on-chip derivatization 
 The goals of this work were to: 1) establish a method for construction of an 
easily assembled, re-usable microdialysis-microchip device; 2) evaluate on-column 
NDA/2ME derivatization for amino acids and peptides on-chip; and 3) incorporate 
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the additional feature of on-chip sample derivatization to our on-line system.  The 
latter was demonstrated by sampling a three-component mixture from a vial by using 
a 4-mm microdialysis brain probe.  The probe was then coupled to the chip device for 
derivatization and analysis.  Figure 2.4 shows the results of this analysis. 
Concentrations of analytes were as follows: 7.95 mM Arg, 10 mM Gly-Pro, and 10 
mM Asp.  Injections were conducted at a very rapid rate (every 30 s), and the 
reproducibility was good (RSD = 8.2, 5.9, and 11.8 % for Arg, Gly-Pro, and Asp, 
respectively; n = 6).   The longevity of the device was determined in part by the run 
buffer.  Analysis could be run around 15 times without replenishing reservoir B or 
reconditioning the chip with NaOH to regenerate the EOF.    
 
2.4. Conclusion 
The incorporation of on-chip sample derivatization was carried out using an 
easily- assembled microchip CE device coupled online to microdialysis sampling.  
This miniaturized analysis system exhibits a high degree of process integration, 
including sample preparation, delivery, sample gating, dynamic derivatization, 
separation, and detection for high-temporal resolution monitoring of biological 
systems.  Future studies will involve improvement of LIF detector sensitivity by 
addition of a pinhole filter, lengthening the separation channel for on-column reaction 
and investigation of a precolumn derivatization scheme to increase fluorescent 
product yield.  The ultimate goal of this work is to develop a micro-total analysis 












Fig. 2.4:  Continuous separations of a 3-component mixture sampled continuously 
through a 4-mm microdialysis probe at a flow rate of 1.0 ml/min.  Analyte 
concentrations are as follows: 7.95 mM Arg, 10 mM Gly-Pro, and 10 mM Asp.  
Derivatization conditions were similar to those used in Figure 2.2. 
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Development of a poly(dimethylsiloxane) (PDMS) based microchip device for 




The brain extracellular space is a complex jelly-like matrix comprised of 
numerous chemical entities such as ions, neurotransmitters, peptides, metabolites and 
extracellular matrix molecules [1]. The analysis of amino acid neurotransmitters in 
the brain extracellular fluid is an important aspect of many in vivo neurochemical 
investigations such as learning and behavior, oxidative stress, seizure, epilespsy and 
other neurological disorders [2-5]. Microdialysis is a popular in vivo sampling method 
that can be used to continuously retrieve analytes from the brain extracellular space 
so that they can subsequently be interrogated by appropriate analytical methods [6]. 
Also, microdialysis sampling studies can provide information on the concentrations 
of exogenous compounds in the extracellular fluid of tissues following administration 
(i.e drug substances) [7].  This sampling technique has been used to investigate drug 
transport and metabolism at the blood brain barrier (BBB) [8]. Pharmacokinetic and 
pharmacodynamic studies performed with microdialysis samples can be used to draw 
conclusions regarding the delivery characteristics of the drug as well as its therapeutic 
efficacy [9,10].  
Brain microdialysis sampling is accomplished by surgically implanting a 
concentric cannula probe into the specific brain region of interest. The probes are 
continuously perfused with a solution of ionic strength similar to the extracellular 
fluid of the region of implantation. Small molecular weight compounds present in the 
extracellular space diffuse across the probe’s semipermeable membrane into the 
continuous flowing perfusate based on the concentration gradient. Microdialysis 
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creates a continuous stream of sample and hence is an ideal technique to be coupled 
to an analytical system that is capable of analyzing discrete sample plugs from a 
continuous stream. The value of developing such analysis systems lies in the ability to 
perform “continuous” and “online” analysis that ultimately results in high throughput 
and temporal resolution. Various online instrumental setups have been reported in the 
literature that involve microdialysis coupled to liquid chromatography (LC) or 
capillary electrophoresis (CE) with laser-induced fluorescence (LIF), mass 
spectrometry (MS), UV or electrochemical (EC) detection scheme [11,12].  
Microchip electrophoresis is a technique that is well suited to perform flow-
through sampling and separation on one integrated device. In addition to advantages 
associated with miniaturization, such systems offer the ability to be custom designed 
to handle, manipulate and inject discrete plugs from pressure driven flows. For in vivo 
continuous monitoring applications, the outlet from the microdialysis probe can be 
coupled directly to the microchip device creating a continuous flow of sample 
through the chip.  Discrete plugs can then be injected by hydrodynamic or 
electrokinetic injection into an electrophoresis channel for separation [13,14]. 
Ultimately, such a system is capable of continuous online near real time analysis of 
microdialysis samples yielding useful information regarding temporal changes in the 
concentration of analyte(s) in the brain or other tissues.  
One of the primary advantages of microchip based devices for the analysis of 
microdialysis sample is the ability to sample from submicroliter flow rates. Low flow 
rates (low microliter to nanoliter per minute) are ideal for microdialysis as this leads 
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to higher relative recovery of the analyte and ultimately improves the limits of 
detection for the integrated device [15]. Such low flow rates are also very compatible 
with microchip devices because they result in lower back pressures and less fluid 
buildup within the device. This provides the opportunity to build microchip devices 
out of less robust substrates (e.g. PDMS) without requiring complicated surface 
modification [16]. 
During the development of a microdialysis-microchip electrophoresis system 
with LIF detection for in vivo application, incorporation of various key components 
into the chip device needs to be considered. These components include a 
microdialysis-chip interface capable of handling the hydrodynamic flow, mixing 
channels for analyte derivatization, a separation channel to accomplish the 
electrophoretic separation and a detector module. Our group reported the first system 
that coupled microdialysis with microchip electrophoresis [17]. Since then, there have 
been a few additional reports of online microdialysis-microchip separation systems 
for in vitro and in vivo applications. Most notable among those is the device 
developed by Kennedy group using glass chips for continuous in vivo monitoring of 
amino acids in rat brain using side-by-side microdialysis probes. This method 
employed microdialysis sampling, precolumn derivatization with OPA and β-ME and 
gated injection followed by amino acid analysis on the chip device [18]. The Martin 
group has also described an innovative method for coupling microdialysis to 
microchip that employs soft lithographic valves that are actuated to inject plugs of 
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sample from microdialysis sample flow. This device has been used to detect 
dopamine release from PC-12 cells in vitro with electrochemical detection [19].  
The present study concerns the development of a PDMS microchip-based 
analysis system that integrates in vivo microdialysis sampling along with reagent 
delivery and mixing by means of hydrodynamic flow for on-chip derivatization 
followed by injection and analysis of the derivatized sample by LIF detection. This 
device utilizes a simple design in PDMS; it is substantially easier to construct 
compared to other devices that employs glass bonding or soft lithographic valves.  
Also, the chip is designed to make it possible to optimize and manipulate flows with 
minimal effort. The system was evaluated for the analysis of amino acid standards 
and rat brain striatum microdialysis samples using naphthalene-2, 3-dicarboxaldehyde 
(NDA) and cyanide (CN) as the derivatization reagents. To the best of our 
knowledge, this is the first report of a PDMS-based microchip device for online in 
vivo analysis. 
 
3.2 Materials and Methods 
 Chemicals and materials: The following chemicals and materials were used: 
boric acid, SDS, acetonitrile, disodium fluorescein, amino acid standards, sodium 
cyanide, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, 
sodium bocarbonate and disodium phosphate were purchased from Sigma (St. Louis, 
MO). Naphthalene-2,3-dicarboxaldehyde was received from Molecular Probes 
(Eugene, OR). All aqueous buffers and solutions were prepared using Milli-Q water 
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and filtered using 0.22 μm Cameo Teflon syringe cartridges from Osmonics 
(Minnetonka, MN).  Brain probes (4mm length, CMA 12) were obtained from CMA 
(North Chelmsford, MA). 
 Chip Fabrication: All microchip devices were fabricated from poly 
(dimethylsiloxane) (PDMS) obtained from Ellsworth Adhesive (Minneapolis, MN).  
Channel molds were prepared on a silicon wafer (Telic Co.) using SU8-10 photoresist 
(Newton, MA) and a high resolution negative transparency (IGI, Minneapolis, MN) 
containing the chip design using standard photolithographic techniques.  
The chip was fabricated by pouring an approximately 5 mm thick layer of a mixture 
of PDMS and curing agent (10.5:1.5) on the channel mold followed by curing for 25-
30 minutes at 90oC in a convection oven. Reservoirs were then punched with biopsy 
punches (4 mm diameter) and inlets for hydrodynamic flow were produced with 20 
gauge luer stub.  A second thin PDMS layer (approximately 1 mm in thickness) was 
semi cured in the oven for 15-18 minutes at 90oC until this PDMS layer was tacky to 
touch.  The channel layer was then conformally contacted with the semi cured layer 
and again cured in the oven at 85oC overnight for a semi-permanent seal. To interface 
the chip with hydrodynamic flow, stainless steel pins were embedded in the flow 
inlets. The other end of each pin was connected to the outlet of a syringe pump or that 
of a microdialysis probe via FEP tubing. 
In vitro experiments:  For these studies, the microdialysis probe was placed in 
a vial containing a solution of the amino acids of interest in aCSF.  The inlet of the 
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probe was connected to a 1 mL syringe containing water via FEP tubing, and outlet of 
the probe was connected to microfluidic device.   
In vivo experiments:  Sprague-Dawley (SD) rats weighing 225g-250g were 
anesthetized by inhalation of isoflurane followed by a subcutaneous (s.c.) injection of 
a  mixture of acepromazine (0.37 mg/mL), ketamine (37.5 mg/mL) and xylazine (1.9 
mg/mL).  Additional doses of ketamine were injected as needed to maintain the level 
of anesthesia during the experiment.  The body temperature of the rat was maintained 
by placing the animal on a heating pad.  The area from the base of the skull to 
approximately the front of the eyes, the hair on the lower abdomen and inner thigh 
were shaved as closely as possible. 
 The animal was placed on its back for insertion of femoral cannula.  A small 
nick was made in the femoral vein and micro-renethane cannula was inserted with aid 
of dental pick.  The incision was closed properly with staples.  The animal was placed 
on its front for implantation of the microdialysis probe. The guide cannula followed 
by microdialysis probe was implanted in the striatum region using stereotaxic 
coordinates: A/P (+0.2), M/L (+3.2), D/V (7.5).  Dental acrylic was applied in the 
area that was shaved to anchor the guide cannula in place.  Post surgery, the animal 
was allowed to recover for 2 hours with simultaneous perfusion of the implanted 
probe with aCSF. 
Microdialysis sampling: For in vivo microdialysis sampling, the brain 
microdialysis probe was implanted in the rat striatum. The input of the probe was 
connected to 1 mL syringe containing artificial cerebrospinal fluid (aCSF was 
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composed of 120mM of NaCl, 3mM KCl, 20mM NaHCO3, 1.2mM CaCl2, 1.0mM 
MgCl2, 0.25mM Na2HPO4) via FEP tubing. The syringe was placed in a syringe 
pump (CMA) and all experiments were performed with a flow rate of 1.0 µL/min for 
each inlet. 
High potassium aCSF studies: For these studies, a liquid switch (CMA) was 
placed between the syringe pump and microdialysis probe that enabled switching 
from aCSF to high potassium aCSF (composed of 20mM of NaCl, 103mM of KCl, 
20mM NaHCO3, 1.2mM CaCl2, 1.0mM MgCl2, 0.25mM Na2HPO4) without 
interruption.  Post recovery, a set of 5 basal microdialysis samples was collected from 
the anesthetized rat and then perfusate was switched to high K+ aCSF followed by 
sample collection.  
Derivatization reactions: For offline analysis, amino acid standards or 
microdialysate were derivatized with equal parts by volume of 7 mM NDA (dissolved 
in acetonitrile) and 10 mM NaCN (dissolved in 50 mM boric acid buffer, pH 9.2). For 
online derivatization, 7 mM NDA (dissolved in 1:1 acetonitrile:H2O) and 10mM 
NaCN (50 mM boric acid buffer, pH 9.2 and 5% acetonitrile) were used.   
Microchip operation: During offline experiments, an injection voltage was 
applied across the sampling channel (50V/cm) and a separation voltage (400V/cm) 
was applied across the serpentine channel. For online experiments, the same injection 
and separation method was followed except that the sample pool reservoir was 
manually cleared of the previous sample and allowed to fill up for approximately 30s 
for the next sample. This procedure was followed for all online experiments.   
 104
LIF detection system: The detection system consisted of an epi-fluorescent 
microscope (Nikon Ti series). The chip device was placed on a microscope glass slide 
(Gold Seal cover glass #3334) and positioned on the microscope stage with clamps. 
Fluorescent light (mercury lamp source connected to the microscope by fiber optic 
cable) was focused at a point of the separation channel usually at a distance of 0.2cm 
from the waste reservoir through a 40X objective. Filter cubes housing the 
appropriate excitation/emission filters and dichroic mirrors were installed inside the 
carousel. Fluorescein studies were performed using FITC filter cube (B1-E) obtained 
from Nikon. For the detection of CBI derivatives, a custom built cube was purchased 
from Chroma (25 mm diameter z442/10X clean-up filter, 25 mm diameter 510hq/50m 
bandpass emission filter and 25.5x36mm laser dichroic filter and transmit 
hq510/50m). A photomultiplier tube (Hamamatsu) was aligned to the side port of the 
microscope to collect the emission from the sample. Data was collected in a computer 
using Chromgraph software that was coupled to the PMT by means of a preamplifier 
(Stanford Research Systems) and data acquisition module (Chromgraph Interface). 
Electropherograms were analyzed using Origin software. 
 
3.3 Results and discussions 
3.3.1 Offline studies and characterization 
Although glass is an ideal substrate for electrophoresis, the fabrication of glass 
microchips is challenging and time consuming. The major challenge is associated 
with the reproducibility of the bonding process used to seal the glass plates.  Several 
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groups have proposed techniques to improve the reproducibility of glass bonding [20-
22]; however, due to the inherent dependence of bonding success on the glass surface 
and microscopic structural defects, there are a number of problems associated with 
the transfer of this technique from one lab group to the next. Also, we have found that 
bonding of complex channel designs in glass can be problematic because of turns and 
angles. Hence, this device was fabricated out of PDMS to make the fabrication facile 
and reproducible.  
Previous research regarding microdialysis-micochip electrophoresis utilized 
microchips with 3 cm separation channel [23]. However, microdialysis samples 
collected from brain extracellular space are quite complex and the separation is more 
complicated requiring greater peak capacity. Therefore, a serpentine channel with a 
separation channel length of 20cm was fabricated and characterized for these studies 
(Fig 3.1A). This design also incorporated a sampling channel (15 μm wide) that was 
narrower than the separation channel (40 μm wide) to facilitate more efficient 
pushback of sample and minimize sample leakage from the sampling to the separation 
channel during application of the separation voltage [24] .  
The procedure for sample injection and separation on this device is illustrated 
in Fig 3.1B.  An injection voltage of 0.3-0.5KV was applied across the sampling 
channel followed by a separation voltage of 400V/cm across the separation channel. 
The optimal injection times were found to be between 0.5-1sec. This injection scheme 
could be adapted quickly for optimization of the serpentine-channel chip for online 






























Figure 3.1: A. Microchip device with serpentine channel specifications. B. Injection 
and separation mechanism on such a device. 
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the separation component of in vivo microdialysis-microchip electrophoresis device, 
this injection method was found to be most easily integratable with the flow through 
sampling that is described later in this chapter. In addition, the short and narrow 
sample injection arms precluded possibilities to carry out gated injection on this 
design. 
Roman et al. reported the development of a PDMS based serpentine 
microchip electrophoresis for high resolution analysis of amino acids and proteins. 
They also reported the use of SDS in the sample buffer to reduce analyte adsorption 
and generate a faster EOF on the chip device [25]. In our case, the separation was 
optimized for neuroactive amino acids by evaluating various buffer conditions 
containing SDS (Fig 3.2). It was empirically observed that a high salt buffer 
containing a high concentration of SDS offered better wetting properties and 
facilitated filling the hydrophobic PDMS channel compared to a low salt, low 
concentration SDS buffer. High currents and consequent Joule heating are considered 
major drawbacks for such buffers. However, in this case, it did not seem to affect the 
performance or the resolution of the devices (N=10 chips).   This was likely due to 
fact that PDMS is gas permeable which provided some degree of heat exchange with 
the surrounding minimizing Joule heating.  
Once the separation conditions were optimized, a set of basal microdialysis 
samples were collected from the rat brain striatum, derivatized offline with NDA and 
CN- and analyzed on the chip (Figs 3.3 and 3.4). The microdialysis samples were  
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Figure 3.2: Optimization of separation of neuroactive amines under various buffer 
conditions on serpentine microchip. A. 20 mM borate, 10 mM SDS, 10% ACN at pH 
= 9.2; V = approx. 500 V/cm; approx. 3.3 uM amino acids; B. 200 mM boric acid, 80 


































Figure 3.3: Peak identification in rat brain microdialysis sample (offline analysis). 
Each peak was identified by spiking the basal sample with 10μM of each analyte. 
Separation conditions are as follows: separation buffer composition is 20mM borate, 









































Figure 3.4: Peak identification in rat brain microdialysis sample (offline analysis). 
Each peak was identified by spiking the basal sample with 10μM of each analyte. 
Separation conditions are as follows: separation buffer composition is 200mM borate, 
80mM SDS, 5% acetonitrile, pH 9.2, separation potential of 400V/cm, injection time 
2 sec. 
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then spiked with glutamate (Glu), aspartate (Asp), GABA and taurine (Tau) for 
confirmation of peak identification.  
 
3.3.2 High K+ infusion 
Infusion with high K+ aCSF has been reported to depolarize neurons thereby 
increasing the concentration of excitatory amino acids in the extracellular space [26]. 
This effect has also been found to be immediate in previous studies [27,28]. Offline 
sample analysis was performed to show the application of this device to monitor in 
vivo concentration changes (Fig 3.5). Peak for Glu and Asp were identified based on 
spiking with standards and comparing their migration times. The data shows an 
increase in Glu after switching to high potassium aCSF.  
 
3.3.3 Online microdialysis sampling and derivatization 
The microchip was then modified for online monitoring. To integrate 
NDA/CN derivatization prior to the electrophoresis separation, additional channels 
for hydrodynamic flow were incorporated into the chip as shown in Figure 3.6. 
Briefly, NDA, NaCN and the microdialysis sample were introduced via 
hydrodynamic flow into the three inlets followed by mixing in the serpentine reaction 
channel. The channels in the mixer were optimized with wider dimensions (120μm) 
in order to avoid pressure buildup which could result in delamination or failure of the 


























Figure 3.5:  Offline analysis of rat brain microdialysis sample following perfusion of 
high K+ aCSF. High K+ leads to depolarization of the cell membrane resulting in the 
increase of glutamate in the brain extracellular space demonstrated here by the 
increase in height of the glutamate peak. Separation conditions are as follows: 
separation buffer composition is 20mM borate, 15mM SDS, 5% acetonitrile, pH 9.2, 
separation potential of 400V/cm, injection time 2 sec. 
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A 2mm inch diameter reservoir was constructed between the derivatization 
and the sampling channel that served as sample pool following derivatization.  The 
reservoir also acted as a barrier between the pressure-driven flow from the 
derivatization channel and electrophoretic flow in the separation channel. This 
configuration made it possible to combine these two, which were optimized 
independently of each other without affecting injection or analysis. In addition, we 
were able to bypass challenging optimization experiments as generation of plugs from 
continuous stream requires a delicate balance between the pressure-driven flow and 
the electrophoretic flow in order to achieve reproducible gating and injection plugs.  
The time scale of sample injection and separation with this approach was 
longer compared to gated injection because of manual intervention to remove sample 
which decreased temporal resolution. However, it also offered us the advantage of 
replenishing the separation buffer reservoirs periodically. For complex samples in 
gated injection scheme, closely eluting peaks can exhibit a loss in resolution as the 
buffer waste reservoir is filled up over time with sample. Eventually this can change 
the run buffer composition including buffer capacity, pH and ionic strength [29]. 
Studies were performed on derivatization channels to optimize the flow rate 
and mixing. To investigate the flow characteristics of the channel, three food dyes 
were used to represent microdialysis, NDA and CN- flow from syringe pump (Fig 
3.6). Micrographs were taken at various positions within the reaction channels. Three 
separate and uniform flow streams were observed at 1μL/min each (total 3μL/min) 
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for individual inlet at the Y-intersection.  It was critical to ensure equal delivery of all 
the three components on chip for subsequent mixing and efficient reaction.  
After establishing consistent flows from all three inlets, mixing was evaluated 
by visual inspection of color homogeneity within reaction channels. Previous reports 
have described alternative approaches to perform mixing in microchannels using 
various channel designs and geometries reviewed in a recent article by Mansur et al. 
[30]. In our design, a few turns were included in the mixer for simplicity. In the 
beginning of the derivatization channel, three separate streams of dye were observed.  
This fluidic behavior is common for microchannels due to the low Reynolds number 
generated from the small dimensions. However, it was observed that the turns 
induced some degree of turbulence in the channels which resulted in uniform mixing 
after the fluids passed through the first few turns (Fig 3.6). Further turbulence and 
mixing can be induced by introducing more turns but in our setup adequate mixing 
was observed to proceed with in vivo experiments. Compared to most previous 
reports, we were able to develop a uncomplicated system that exhibited mixing at low 
flow rates 0.5-1uL/min (for each inlet) from the syringe pump; however, quantitative 
analysis on mixing efficiency was not performed. 
 
3.3.4 Online derivatization and sampling with change in concentration 
In the first report of an online microdialysis microchip electrophoresis 
systems, Huynh et al. demonstrated in vitro change in concentration of fluorescein 






























Figure 3.6:  Demonstration of mixing in the serpentine derivatization channels. The 
micrographs in the panels reveal the flow pattern at various points of the 
derivatization channel. Compared to the left micrographs (segregated flow pattern 
due to low Reynolds number in microchannel), the right micrographs reveal a 




probe to injection) of approximately 6.5mins. Sandlin et al. reported being able to 
monitor a step change in Glu concentrations from 0 to 100uM at various flow rates 
and their effect on the response time of 2 - 4mins. 
In our chip the reaction and separation components were optimized separately.  
As with the previous online systems, we were interested in determining the response 
time of the system to a change in amino acid concentration via a microdialysis probe. 
Such an experiment was thought be more relevant than demonstrating concentration 
change with fluorescein or a single analyte in terms of in vivo applications with 
complex biological samples.  Online sampling and derivatization was investigated in 
vitro for six amino acids (Glu, Asp, Gly, Tau, Arg, Trp) with 10X concentration 
change from 500nM to 5mM.  The microdialysis sample was injected continuously 
and the change in response versus time is shown in Figure 3.7.  The lag time (time 
between when the sample was introduced into the probe and when the change was 
detected) was approximately 25 minutes. There are few factors that contributed to this 
relatively long lag time, including dead volume from tubing length, flow rate and 
manual intervention during injections that increased analysis time for each run. The 
response time was not measured due to the time gap between the sample injections. 
Further studies will consider modifications needed to perform high throughput studies 



































Figure 3.7: In vitro concentration change study with online derivatization of amino 
acids with NDA/CN-. The concentration of amino acids was increased from 500nM to 
5 μM at t = 15 mins. The lag time and the response times are indicated in the figure. 
Separation conditions are as follows: separation buffer composition is 20mM borate, 
15mM SDS, 5% acetonitrile, pH 9.2, separation potential of 400V/cm, injection time 
2 sec. 
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3.3.5 In vivo monitoring 
Fluorescein has been used extensively as a marker for passive permeability at 
the blood brain barrier. To evaluate the capability of the device for in vivo 
experiments with fluorescein were performed. A rat was injected with a bolus dose of 
0.5mg of fluorescein via femoral vein; followed by microdialysis sampling from the 
striatum and online analysis on chip. Fluorescein appeared in the microdialysate 
within five minutes after injection (Fig 3.8). Over a period of 90 mins, there was a 
decrease in fluorescein peak height suggesting evidence of clearance. It has been 
reported in the literature that fluorescein is cleared from the body via renal excretion, 
metabolism in liver and excretion via feces. Although no rigorous pharmacokinetic 
treatment was performed on the data, it was qualitatively demonstrated that this 
device can theoretically be used for quantitative assessment of changing analyte 
concentration in an in vivo setup. The time scale of clearance obtained in these studies 
is in agreement with previous publications [31,32]. 
To demonstrate an online in vivo application of microdialysis coupled to a 
microchip device, online microdialysis sampling was performed in the rat brain 
striatum followed by derivatization and analysis on the chip device. A method for 
separation of Glu and Asp in the microdialysis sample was developed earlier using 
offline sampling. Fluorescein was also incorporated into the separation as an 
exogenous compound as a marker for blood brain barrier (BBB) permeability.  
A representative electropherogram from such a study is shown in Figure 3.9. 





































Figure 3.8: Online in vivo analysis of fluorescein from rat brain microdialysate. The 
fluorescein was administered via IV bolus dose in the femoral vein of SD rat. The 
bottom figure shows the graphical representation of the continuous set of injections 
shown at the top panel. Electrophoresis conditions are same as Figure 3.7. 
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peak height in Figure 3.9, , we were able to obtain reproducible runs (RSD 8.5% for 
Glu, 4.6% for Asp, N = 4 injections).  The migration order is well in agreement with 
offline analysis and standard runs based on their migration time. A major concern for 
PDMS devices is adsorption of analytes and buffer components to the surface of the 
chip resulting in gradually deteriorating separation characteristics. However, we were 
able to run these chips for approximately 2 hours (N = 5 chips) without appreciable 
loss of resolution or signal. Such observations were probably a consequence of the 
ability to replenish buffer on this chip device at regular intervals without stopping the 
flow from the syringe pump and the microdialysis probe. In a gated injection 
approach, changing the buffer requires stopping the voltage which can result in 
flooding of separation channel with sample creating carry-over problems during 
subsequent analysis. These series of injections successfully demonstrated that the 
system is capable of monitoring the appearance of fluorescein in the brain as well as 

































Figure 3.9: In vivo continuous monitoring with online derivatization of amino acid 
neurotransmitters (glu and asp) with fluorescein as the exogenous compound. 
Separation conditions same as Figure 3.7. 
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3.4 Conclusion 
This work demonstrates the applicability of PDMS-based microchip devices 
for online in vivo studies. Previous reports of such devices included glass microchips 
and PDMS valving system, both of which can be challenging to implement. Also, 
microchips containing PDMS based valving suffer from the lack of ability to be 
scaled down to true miniaturized devices as multiple gas tanks are required to activate 
the valves. This study aimed to perform online in vivo sampling utilizing a simple 
design and fabrication technique that were easily adaptable for different kinds of 
experiments and labs. Optimization studies can be carried out separately and then 
combined in the same integrated device.  With precise integration and automation for 
sample and buffer fill/removal, such a device can potentially be scaled down to a true 
miniaturized device. All of the fluidics inside this device are dictated by the 
application of voltage and not by hydrodynamic to electrophoretic flow balance as is 
the case with a gated injection. Also, this chip can be modified to perform high 
temporal resolution studies which will be the scope of a future publication. The 
ultimate goal is to apply this device to investigate changes in concentrations of amino 
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Development of a PDMS based microdialysis microchip device for continuous 




Microdialysis is a well characterized sampling technique that can be utilized 
to continuously recover analytes in vivo. Cerebral microdialysis is an important tool 
to study neurochemistry of the brain [1]. An important issue associated with 
performing chemical investigations in the CNS is the time scale of these events. 
Chemical signaling in the brain covers a wide dynamic range (Fig 4.1). The process 
of neurotransmission involves substance being released by one neuron and acting 
rapidly, briefly, and at short range on the membrane of an adjacent neuron, causing 
excitation or inhibition [2]. In order to measure fast dynamic changes in concentration 
of neurochemically active species possibly triggered by disease state or by a 
therapeutic drug, the temporal resolution of analysis is an important consideration. 
There has been considerable interest in the literature in coupling microdialysis 
sampling with capillary electrophoresis (CE) to generate integrated online systems 
capable of performing in vivo analysis with high temporal resolution. Temporal 
resolution of an analytical system can be defined as the shortest interval of time that 
is necessary between repeated analyses. The limiting factors that affect temporal 
resolution in online systems can be scrutinized in terms of properties of the 
microdialysis probe as well as capabilities of the analysis method. For monitoring 
compounds with high endogenous concentration (glutamate, aspartate) in an online 
separation based system, the temporal resolution is dictated by the analysis time.  
One of the major concerns associated with microdialysis is analyte recovery 








Fig 4.1: Timescale of chemical signaling in the nervous system [13]. 
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precisely measure rapid concentration changes occurring in the extracellular space, 
the analyte concentration in the perfusate must be in equilibrium with the external 
concentration. However, since microdialysis is a dynamic method where perfusate is 
constantly being removed, such equilibrium is not reached. The concentration 
difference between the analyte recovered in the perfusate and the analyte in the 
extracellular space is dependent on perfusion flow rate, probe size, molecular weight 
(MW) cutoff of the membrane, temperature, analyte properties and composition of 
the external matrix [3]. The relative recovery of analyte increases exponentially with 
decreased perfusion rate. A high precision syringe pump is necessary for 
microdialysis applications to ensure changes in recovery are due to changes in analyte 
concentration in the brain and not due to alterations in concentration gradient 
produced by flow rate changes from the pump [4]. Increasing membrane size (length 
or diameter), while increasing recovery, will decrease spatial resolution and induce 
more tissue damage. Therefore, the consistency of probe recovery with alterations in 
brain chemistry is necessary to perform meaningful high temporal resolution analysis.  
The analysis system needs to possess certain features to perform high 
temporal resolution studies. First, the detection scheme should be sensitive enough to 
detect analytes of interest in the microdialysis sample. Second, the system should be 
able to perform injections and separations as frequently as possible. The rate of 
perfusion through the microdialysis probe and the sensitivity of the detection system 
are the interrelated factors that affect the value of temporal resolution. For instance, 
low flow rates (low μL to nL) through microdialysis probe leads to higher mass 
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recovery of analytes. However, these low flow rates also yield less volume of sample 
in a given period of time. In some cases, the analysis system must wait for the 
required length of time to obtain enough sample for injection. On the other hand, high 
flow rates can produce required requisite sample volumes faster but will be more 
dilute due to lower relative recovery rates compared to the previous case. In such 
cases, the sensitivity of the detection system needs to be high so that it is capable of 
detecting low concentration analytes in the microdialysate. To mitigate detection 
issues, fluorescence is the most popular detection mode for online systems due to its 
high sensitivity.  
Microchip electrophoresis is an attractive platform for online pairing of 
microdialysis with electrophoresis separations because of its small sample volume 
requirements (nL), small footprint, ability to perform fast, highly efficient separations 
and easy integration of fluorescence detection. Also, chips can be custom-designed 
based on application and additional sample prep steps (such as derivatization reaction 
for fluorescence detection) can be built in. Our group has previously reported flow 
through devices with short separation channels for analysis of amino acids and 
peptides as well as serpentine channels for the detection of amino acid 
neurotransmitters in vivo brain microdialysate samples (chapter 3).  
The present study is targeted towards the development of a microchip device 
with high temporal resolution capabilities for monitoring neuroactive amino acids. 
These chips incorporated a precolumn derivatization step with NDA and CN-. In this 
chapter, flow-through sampling techniques (includes chip fill up, sample flow, 
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derivatization, gated injection and separation) were systematically optimized on chip 
[5] to render the chip more practical for in vivo analysis. The chip device was 
fabricated from poly(dimethylsiloxane) (PDMS) and incorporated straightforward 
method for buffer refill, equilibration and bubble removal without disturbing the 
microdialysis flow. The chip was characterized in terms of reagent mixing with 
microdialysate by hydrodynamic flow (for online derivatization) and high temporal 
resolution analyses were performed with amino acid standards. Online concentration 
change experiments were also performed to demonstrate the suitability of the chip for 
in vivo measurements.  
 
4.2 Materials and Methods 
Chemicals and materials: The following chemicals and materials were used: 
boric acid, SDS, acetonitrile, disodium fluorescein, amino acid standards, sodium 
cyanide, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, 
sodium bicarbonate and disodium phosphate were purchased from Sigma (St. Louis, 
MO). Naphthalene 2,3 dicarboxaldehyde was purchased from Molecular Probes 
(Eugene, OR). All aqueous buffers and solutions were prepared using Milli-Q water 
and filtered using .22 um Cameo Teflon syringe cartridges from Osmonics 
(Minnetonka, MN).  Brain probes (CMA 12) obtained from CMA (North Chelmsford, 
MA). 
Chip Fabrication: All microchip devices were fabricated from PDMS obtained 
from Ellsworth Adhesive (Minneapolis, MN).  Utilizing standard photolithographic 
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techniques, channel molds were prepared on silicon wafers (Telic Co.) using SU8-10 
photoresist (Newton, MA) and a high resolution negative transparency (IGI, 
Minneapolis, MN) containing the chip design. Then, approximately a 5 mm thick 
layer of a mixture of PDMS and curing agent (10.5:1.5) was poured onto the channel 
mold followed by curing for 25-30 minutes at 90oC in a convection oven. Following 
this, the reservoirs were produced with biopsy punches (4 mm diameter) and inlets for 
hydrodynamic flow were produced using a 20 gauge luer stub.  Another thin PDMS 
layer (approximately 1 mm) was semi cured in the oven for 15-18 minutes at 90oC 
until it was tacky to touch.  Then the channel layer was conformally contacted with 
the semi cured layer and cured in the oven at 85oC overnight for semi-permanent 
contact. The chip was interfaced with hydrodynamic flow using steel pins that were 
embedded in the flow inlets. The other end of the pin was connected to the outlet of a 
pump or that of a microdialysis probe via FEP tubing. 
In vitro experiments:  For these studies, a brain microdialysis probe (4mm 
membrane length, CMA, Sweden) was placed in the vial containing the amino acids 
of interest.  The inlet of the probe was connected to 1mL syringe pump containing 
water via FEP tubing, and outlet of the probe was connected to microfluidic device.   
Derivatization reactions: For offline analysis, amino acid standards or 
microdialysates were derivatized with equal parts by volume of 7 mM NDA 
(dissolved in acetonitrile) and 10 mM NaCN (dissolved in 50 mM boric acid buffer, 
pH 9.2). For online derivatization, 7 mM NDA (dissolved in 1:1 acetonitrile:H2O) 
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and 10mM NaCN (50 mM boric acid buffer, pH 9.2 and 5% acetonitrile) was used. 
The flow rate for each inlet was optimized at 1μL/min (total flow = 3 x 1μL/min). 
Chip operation: For offline studies, a voltage of 2.7 KV was applied at the sample 
reservoir (SR), -5KV was applied at the sample waste (SW) with zero voltage at 
buffer reservoir (BR). For separation, the same voltages were applied except that 5 
KV was applied at BR (Fig 4.2A). For online analysis, voltages of +5KV and -5KV 
were applied to the side channel and end of separation channel respectively. For 
sample injection, the separation voltage was stopped during the period of injection 
(0.5s). 
LIF detection system: The detection system consisted of an epi-fluorescent 
microscope (Nikon Ti series). The chip device was placed on a glass microscope slide 
(Gold Seal cover glass #3334) and positioned on the microscope stage with clamps. 
Fluorescent light (mercury lamp source connected to the microscope by fiber optic 
cable) was focused at a point of the separation channel usually at a distance of 0.2 cm 
from the waste reservoir through a 40X objective. Filter cubes housing the 
appropriate excitation/emission filters and dichroic mirrors were installed inside the 
carousel. Fluorescein studies were performed using FITC filter cube obtained from 
Nikon. For analysis of NDA derivatives, a custom built cube was purchased from 
Chroma (25 mm diameter z442/10X clean-up filter, 25 mm diameter 510hq/50m 
bandpass emission filter and 25.5x36mm laser dichroic filter and transmit 
hq510/50m). A photomultiplier tube (Hamamatsu) was aligned to the side port of the 
microscope to collect the emission from the sample. Data was collected in a computer  
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that was coupled to the PMT by means of a preamplifier (Standford Research 
Systems) and data acquisition (Chromgraph Interface) module. Electropherograms 
were analyzed using Origin software. 
 
4.3 Results and discussions 
4.3.1 PDMS-based microchip device. 
The chip devices used in this study were fabricated from PDMS. Most reports 
for online microdialysis microchip setups have utilized glass devices for analysis 
[6,7]. However, glass microchip fabrication can be quite challenging due to problems 
associated with thermal bonding of the glass plates containing etched channels. Other 
bonding methods (Calcium-assisted bonding) have proved to be quite unreliable in 
our lab setting [8]. Although PDMS suffers from drawbacks compared to glass for 
electrophoresis separation in terms of hydrophobic analyte adsorption and surface 
modification leading to slow deterioration of EOF, there have been an extensive 
number of publications that use PDMS because of ease of construction and 
reproducibility. The present study makes use of simple and standard fabrication steps 
to construct the PDMS devices. Also, a trouble-free, robust and reproducible interface 
using steel tubing was used for coupling hydrodynamic flow to the chip. This did not 
require expensive nanoports (Upchurch) which are generally thought to be unsuitable 





4.3.2 Optimization of gated injection in a serpentine chip (offline analysis). 
For the development of a microdialysis microchip electrophoresis system for 
high temporal resolution, rapid injection and separation of samples on chip device is 
essential. Electrokinetic gating is the easiest method to implement ultrafast injections 
that does not require intricate fabrication steps (e.g. soft lithographic valving). Gated 
injection in serpentine microchips has been employed in a few published reports 
[6,9,10].  
One such device, based on a report by Sandlin et al., is shown in Figure 4.2A 
[6]. In our chip based on this design, a voltage was applied to create EOF which 
would push the sample from the top reservoir and simulate the hydrodynamic course 
for flow-through injection. Offline analysis with fluorescein was performed on this 
chip (electropherogram not shown). Acceptable RSD values for peak heights at 4.2% 
(N = 7 inections) were obtained for fluorescein. Analysis of NDA derivatized 
glutamate, aspartate and OPS (internal standard) also exhibited good precision; peak 
height RSD values for glutamate, aspartate and OPS were calculated to be 2.98%, 
3.61% and 5.90% based on 5 injections (Fig 4.2B).  
 
4.3.3 Optimization of mixing in reaction channels. 
 Huynh et al. reported the development of flow-through sampling with on-chip 
derivatization [11]. The first goal of this study was to develop an efficient precolumn 





























Fig 4.2: A. Chip design and injection for offline simulated flow-through studies [6]. 
Sample was injected from SR electrokinetically with SR at 2.7KV, BR at 0KV and 
SW/BW at -5KV. Separation was performed with SR at 2.7KV, BR at 5KV and 
SW/BW at -5KV. B. Separation of 7μM glutamate, aspartate and ortho-
phosphoserine (OPS, an internal standard) with temporal resolution of 15s. The 
continuous set of electropherograms in the bottom panel shows a set of continuous 
injections and separations. Separation buffer: 20mM borate, 10mM SDS, 10% 
acetonitrile, pH 9.2. 
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chip. Chiefly, two mixing channel designs were evaluated. These were designs based 
on reports by Ismagilov et al. (called Design 1 in this paper) [12] and dolomite 
micromixer chip from Dolomite Microfluidics (Design 2).  
First, the flow rate of the analyte and reagent delivery into the chip was 
optimized for each design. Since efficient derivatization would require the delivery of 
all three reagents at approximately equal volumes, the stream width of the individual 
flows were assessed with food color to get an idea of uniformity of liquid delivery. In 
design 2, (Fig 4.3-panel A) uniform delivery was accomplished at 0.5 μL/min for 
each flow. Micrographs taken at a few other areas (Fig 4.3-panels B and C) further 
down the reaction channel showed evidence of mixing by splitting up and reuniting 
the streams. This design was further tested for NDA/CN- reaction by observing the 
actual fluorescence generated by the reaction. Bright fluorescence was observed with 
standard solution of aspartate (1mM) indicative of its online reaction with NDA/CN- 
(Fig 4.4 – panels B and C).  
Parallel studies were performed with design 1 (Fig 4.3D), where the channel 
joins the flow stream later and was intended to simulate addition of NDA following 
mixing of amino acids and NaCN. However, with this design we were not able to 
generate reproducible flow patterns after several trials at flow rates 0.5-1 μL/min. 
Also superior mixing was demonstrated by design 2. Hence further studies were 







































Figure 4.3: A-C: Design and characterization of dolomite micromixer-based chip. 
The micrographs with colored dyes show the flow and mixing pattern in various 
locations of the derivatization channel. Panel C shows segregated flow streams 
whereas D demonstrates a uniform color pattern indicating mixing.  D: Microchip 


































Figure 4.4: Characterization of micromixer chip with 1 mM glycine, 7mM NDA in 
acetonitrile, 10mM NaCN in 50mM borate buffer at pH 9.2. Panel A shows the flow 
profile at the junction where NDA, CN- and microdialysate flows converge. The 
micrographs (B, C) demonstrate the fluorescence in the derivatization channels. 
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4.3.4 Chip modifications for flow through analysis.  
A flow through design was reported by the Chen group [5] for nonstop 
injection and sample analysis from an uninterrupted flow stream. The present design 
has added increased complexity with respect to addition of a derivatization channel, a 
serpentine separation channel and use of hydrophobic PDMS as the chip substrate. 
The first challenge that needed to be overcome with such a design was to be able to 
fill up the appropriate channels of the chip reproducibly and easily with background 
buffer and analyte with reagents without affecting each other. Also the microdialysis 
and buffer solutions needed to be equilibrated within the PDMS microchannels for 
better chip performance (e.g. resolution and reproducibility). The addition of an inlet 
for easy buffer fill with a syringe pump from the bottom of the chip proved to be a 
key solution for several problems. After the start of analyte (amino acid) and reagent 
(NDA/CN-) flow through the derivatization channels, air pockets were created in the 
unfilled spaces within the PDMS channel. Over time the air pockets get pushed into 
the separation channel and ultimately impede the sample injection and separation. 
Subsequent introduction of the separation buffer at a high flow rate (20-30 μL/min) 
not only directed the bubbles exclusively towards the sample waste but also prevented 
the derivatized analyte from filling up the separation channel. This also ensured that 
all the streams were being maintained in the appropriate channels for equilibration 
without bubble creation. Once the chip was equilibrated in such a manner, injection 
and separation could be carried out reproducibly without any problem. 
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4.3.5 Continuous analysis of offline derivatized amino acids. 
A mixture of 5μM amino acids, that were derivatized offline, was analyzed 
online on chip (Fig 4.5) to evaluate injection from continuous flow. The peak height 
RSD values for serine, GABA, glutamate, aspartate and OPS were calculated to be 
2.78%, 3.26%, 3.04%, 2.89%, and 3.17% (<5% for all amino acids) respectively.  
Also, a concentration change experiment was performed with glycine, glutamate and 
aspartate (Fig 4.6) where the concentration change was made at the microdialysis 
probe vial from 1 μM to 4 μM for all amino acids. The rise time was calculated to be 
approximately 2 mins for the setup. 
 
4.3.6 Online derivatization and analysis. 
To demonstrate the performance of the chip after initial design and flow 
optimization studies, online derivatization of amino acids followed by analysis was 
performed. First, injection was optimized for glutamate and aspartate (Fig. 4.7). An 
injection time of 0.1s was chosen as optimum based on the separation resolution. The 
online derivatized amino acids (namely glutamate and asp) exhibited RSD values of 
less than 5% (N = 15 injections). Based on an injection plug size of 10μm length with 
amino acid concentration of 10μM, approximately 80 fmoles of each amino acid was 
injected.  LOD studies were not performed with the precolumn derivatization 
approach used here. In the literature, LODs of 0.08, 0.09 fmol for glu and asp 
respectively have been reported for precolumn detection with OPA and β-























Figure 4.5: A. Online flow through sampling analysis with prederivatized amino 
acids 5mM serine, GABA, glutamate, aspartate, ortho-phosphoserine (OPS, internal 
standard) with temporal resolution of 25s. Separation buffer: 20mM borate, 10mM 
SDS, pH 9.2, injection time 0.5s, 500V/cm separation voltage. The micromixer chip 


































Figure 4.6: Concentration change experiment with prederivatized glycine, glutamate 
and aspartate. The top panel shows a snapshot of the rise time (from 9 mins to 12 
mins). The bottom panel demonstrates the continuous injections and separations with 
concentration changes at 2 points (1μM to 4μM and then to 8μM indicated by the 
arrows). Buffer conditions: 20mM borate, 10mM SDS at pH 9.2. The amino acids 
were derivatized with 7mM NDA in acetonitrile, 10mM NaCN in 50mM borate 

































Figure 4.7: Online derivatization of 10μM of glutamate and aspartate. Injection times 
(1s, 0.1s and 0.07s) were optimized for baseline separation of the analytes. Separation 
buffer: 20mM borate, 10mM SDS, pH 9.2. Online derivatization was performed with 
7mM NDA in acetonitrile, 10mM NaCN in 50mM borate buffer at pH 9.2. The 
separation potential was 500V/cm. 
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performed where the concentration of glutamate was increased from 3 μM to 10 μM 
(Fig 4.8). The rise time in this case was noted to be 5 mins compared to 2 mins in 
case of prederivatized sample. It has been reported that NDA and NaCN takes 3 to 5 
mins for complete reaction with primary amines. However, the underlying 
assumption is that all the 3 analytes are added to a single vial followed by agitation. 
In the case of online reaction, the lack of active vigorous mixing phenomena in the 
reaction channels possibly lengthened the reaction time. Therefore, when the 
concentration changes, the varying analyte mass takes a longer period of time to meet 
the NDA and CN- molecules for efficient reaction. However, in case of prederivatized 
amino acids, the only limiting factor for the concentration change was the probe 
recovery. Another factor that may have affected the change is concentration is Taylor 


























Figure 4.8: Online derivatization with concentration change of glutamate 
demonstrating the rise time (8 mins to 13 mins) of approximately 5 mins. Separation 
buffer: 20mM borate, 10mM SDS, pH 9.2; separation potential 500V/cm. 
Derivatization was performed with 7mM NDA in acetonitrile, 10mM NaCN in 50mM 
borate buffer at pH 9.2. 
 
3 μM to 10 μM 
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4.4 Conclusion 
The primary goal of this study was to develop an easily fabricated microchip 
coupled to microdialysis to perform high throughput sampling with precolumn 
derivatization. Designs were optimized in this study for such a system followed by 
characterization with final online in vitro analysis of amino acids. Additional features 
were integrated into the device for practical consideration of fluid flow. The ultimate 
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Over the previous data chapters, the evolution of the application of online 
microdialysis-microchip electrophoresis systems from the monitoring of a simple in 
vitro reaction to the much more complicated in vivo applications with precolumn 
derivatization has been demonstrated. In the second chapter, a simple-T (3cm 
separation) hybrid PDMS-glass based chip system was developed for on-column 
derivatization of amino acids and peptides with NDA/β-mercaptoethanol as the 
derivatization reagents. Chapter 3 focused on the development of a system that was 
applied for in vivo applications. A serpentine separation channel (20 cm) was 
incorporated into the chip to obtain a higher plate number for better resolution of 
glutamate and aspartate from other amino acids in brain microdialysis samples. Also, 
a simple scheme for the precolumn derivatization of primary amines with NDA/CN- 
was added on-chip that allowed injection and separation of plugs of microdialysate 
containing the analytes of interest (amino acid neurotransmitters). This was 
demonstrated by monitoring aspartate and glutamate in the microdialysis sample of 
an anesthetized Sprague-Dawley rat. Fluorescein, a passive permeability marker at 
the blood brain barrier, was also incorporated in the analysis to allow possibility to 
simultaneously monitor the levels of excitatory neurotransmitters and integrity of the 
blood brain barrier. In Chapter 4, the microchip system was further modified to 
perform continuous injections and separations for high temporal resolution analysis. 
A more complex mixing scheme for precolumn derivatization was incorporated into 
the chip design and was characterized for derivatization efficiency. The chip was 
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evaluated for the separation of prederivatized as well as on-chip derivatization (with 
NDA/CN-) of amino acids.  
 
 5.2 Short-term future directions 
An important in vivo application of an online microdialysis-microchip system 
is the ability to monitor fast in vivo concentration changes. We demonstrated the 
effect of high K+ on brain glutamate levels by offline analysis on chip (Chapter 3). 
Therefore, one of the immediate goals is to use the setup to monitor in vivo changes 
in neurotransmitters (glutamate). This can then be extended to other analytes of 
interest such as aspartate, taurine and γ-aminobutyric acid (GABA, an inhibitory 
neurotransmitter). For such applications, the online system developed in Chapter 4 
can be employed to achieve high temporal resolution. 
Most of the work done in this thesis concerns proof-of-concept studies 
towards the  development of microdialysis-microchip devices for in vivo sampling. 
However, a more thorough characterization of various chip factors is required that 
include (i) effect of background electrolyte (e.g. aCSF containing high concentration 
of salts) in case of electrokinetic injection of multiple analytes (injection bias), (ii) 
adsorption of CBI derivatives by PDMS, (iii) the precise length of separation required 
for adequate resolution and (iv) effect of turn geometry (tapered vs. non-tapered) on 
band broadening. Such studies will help identify the proper design/fabrication 
modifications of the chip for improvement in analytical performance. Also, 
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evaluation of such parameters will help in extracting reliable quantitative information 
from chip analysis.  
In this thesis, the derivatization channel designs were approached in a simple 
manner in terms of building serpentine channels (Chapter 3) and a slightly more 
complex “ladder design” (Chapter 4). However, more thorough studies need to be 
done for fast and efficient mixing. A simple solution is the incorporation of “wedges” 
or “posts” in the mixing channels to induce high turbulence.  
With respect to the microchip analysis systems, efforts should be directed 
towards making the detection spot size (approximately 0.5 mm in diameter currently) 
smaller; this can be achieved by integrating a “pinhole” in the current setup or by 
setting up a microscope system incorporating a laser source that can be focused to a 
spot by using motorized irises. Detection can also be performed with an avalanche 
photodiode (APD) instead of a photomultiplier tube (PMT) to increase the sensitivity 
of detection.  
 
5.3 Long-term future directions 
The temporal relationship between the release of excitatory neurotransmitters 
(glutamate) and loss of blood brain barrier (BBB) integrity is an ideal in vivo system 
to apply the online microdialysis-microchip setup with high temporal resolution 
analysis. Glutamate excitotoxicity has been associated with the breakdown of the 
BBB during ischemic stoke [1].  The microdialysis-microchip system could be 
employed to obtain direct evidence that NMDA receptor stimulation causes loss of 
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BBB integrity. For such investigations, microdialysis probes will be implanted in the 
rat striatum and focal cerebral ischemia will be induced in the animal using accepted 
methods (Rose Bengal) [2]. At the same time, sodium fluorescein will be 
administered continuously by IV infusion. After the induction of stroke, it is expected 
that a sudden increase in the concentration of glutamate would be observed as well as 
an increase in the concentration of fluorescein in the brain probe. The increase of 
fluorescein levels in the brain correspond to the opening of the BBB. Also, the near 
real-time monitoring will give us an idea of the time interval between stroke and 
opening of the BBB in the rat stroke model. 
In order to determine if NMDA receptor stimulation by glutamate is directly 
responsible for BBB opening, an NMDA receptor agonist (NMDA) can be delivered 
via the microdialysis probe to the brain interstitial space. The agonist will prevent any 
interaction of glutamate with the NMDA receptor. If such receptors are involved in 
the augmentation of BBB permeability, then this should be inhibited by the agonist. 
In a separate experiment, a competitive inhibitor of NMDA receptor (AP-5) will be 
delivered [3]. In this case, some glutamate will still be available to interact with the 
receptor and less disruption of the BBB should be observed if glutamate is directly 
involved in the opening of the BBB (i.e. the concentration of fluorescein should be 
less compared to the previous case). Based on such experiments, further studies can 
be conducted to elegantly pinpoint the exact NMDA receptor subtypes responsible for 
opening of BBB. 
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The online microdialysis-microchip system can also be used to monitor matrix 
metalloproteinase (MMP) and its relation to BBB opening. MMPs are responsible for 
the breakdown of extracellular protein matrix. Therefore it has been suggested that 
following stroke, MMPs are activated and become responsible for slow disintegration 
of the BBB [4]. Also, the time scale between the onset of enzyme action and loss of 
BBB integrity is not fully understood. The experiment can be designed in the 
following manner. First, a fluorogenic substrate of MMP can be delivered using the 
microdialysis probe with a suitable molecular weight cutoff. The advantage of online 
derivatization system is that in vivo MMP activity can be monitored even in the 
absence of fluorescent substrates for LIF detection. Using the online microdialysis 
microchip electrophoresis system, it may be feasible to simultaneously monitor the 
activity of the MMPs and the integrity of the BBB (monitored by fluorescein). It is 
also imperative that in vitro separation method development be performed for the 
metabolite of the MMP substrate and fluorescein before performing in vivo 
experiments. 
The near-real time high temporal resolution monitoring capability of 
microdialysis-microchip system will help in understanding the sequence of biological 
events following ischemia including glutamate excitotoxicity and the activation of 
MMPs, all of which lead to the disintegration of the BBB. Overall, this can provide 
scientists with valuable information regarding the time course of events which will 
help to better establish the time window available for critical therapeutic measures in 























Figure 5.1: Schematic showing interaction between different compounds and 
opening of BBB. (“?” indicates possible interactions that may be elucidated through 
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Proteins play a vital role in the regulation of various processes in the body. 
Many proteins are metabolic enzymes that can catalyze biochemical processes in the 
body.  Proteins serve an important role in the formation of receptors and channels in 
membranes and provide structural and mechanical support for the cells and organs. 
Proteins are also important in cell signaling and generation of immune responses. 
Proteins are composed of an amino acid sequence that is encoded in the genetic code. 
During the synthesis or shortly after synthesis, proteins can undergo chemical 
modifications (post-translational modification) such as phosphorylation, acylation, 
glycosylation which alter the structure and activity of the protein [1].  
In recent years, a lot of focus has been placed on developing protein-based 
pharmaceuticals because of certain advantages offered by such compounds over small 
molecule drugs. Protein therapeutics are generally capable of performing highly 
specific and complex set of functions without interfering with normal biological 
processes resulting in less side effects. Protein molecules are endogenous to the body 
and therefore there is a greater chance of tolerance of such protein pharmaceuticals 
without producing an immune response [1]. Protein pharmaceuticals are prone to 
several post-translational modifications that affect their efficacy and shelf life and in 
certain cases can also trigger deadly immune responses against the protein. The 
modifications that are of importance include glycosylation, misfolding and 
aggregation, proteolytic cleavage, deamidation of asparagine and glutamine and 
oxidation of methionine [2]. 
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Oxidation is a one of the major problems associated with the chemical 
degradation of protein and peptide formulations. This degradation process or reaction 
can arise during any of the processing steps (protein isolation, purification) as well as 
storage. Oxidation of protein formulations can lead to alterations in tertiary structure 
(conformation) causing immunogenicity and loss of therapeutic efficacy. Oxidation 
can occur due to the presence of contaminants, such as peroxide present in various 
formulation additives (polyethylene glycol, Polysorbate 80). Autooxidation is 
mentioned as another pathway through which proteins can undergo oxidation; such 
reactions are catalyzed by the presence of trace metal ions which can originate from 
buffer(s) used during processing and formulation. Oxidation can also be induced by 
light and this is a concern for photosensitive formulations. Strategies to minimize 
oxidation include chemical methods such as site directed mutagenesis where the 
reactive amino acid residues are either changed to an alternative less reactive or 
unreactive amino acid or the reactive site of the amino acid is blocked through 
chemical modifications. Physical methods to increase oxidation stability include 
lyophilization (freeze drying) or addition of chemical additives in the formulation 
such as antioxidants and chelating agents. Altering the solution pH, changing the 
buffer species, reducing levels of molecular oxygen or the addition of oxygen 
scavengers have also been proposed for enhancing stability against oxidation [3].  
Methionine is the primary amino acid residue vulnerable to oxidation. Several 
reports have indicated alterations in biological functions of proteins following 
methionine oxidation [4-5]. The various reaction mechanisms through which 
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Methionine can be oxidized are demonstrated in Figure 6.1; cysteine, histidine, 
tyrosine and tryptophan can also undergo oxidation by various mechanisms. 
The addition of hydrogen peroxide (H2O2) is a convenient approach to study 
protein oxidation as the identity and concentration of initial oxidant is known and can 
be controlled [6]. Traditionally, hydrogen peroxide was found to react with those 
residues that are easily accessible on the surface of the protein rather than the residues 
that are buried within the protein; however, recent studies have shown that both 
exterior and masked residues in proteins are affected by H2O2 [7]. 
 Antibodies or immunoglobulins (Ig), first identified in 1890, can be classified 
as an important group of protein therapeutics. Immunoglobulin G (IgG), a 150 kDa 
glycoprotein, is the most abundant antibody found in the serum and is the most 
popular for the development of therapeutics. Such proteins have antigen recognition 
sites which are generally exploited to guide the immune system for targeted 
destruction of molecules or cells. Another mechanism of action of antibodies can be 
the occupation of the functionally important region of the molecule. IgGs consist of 
four polypeptide chains, two identical “heavy chains” (50-55 kDa) and two identical 
“light chains” (approximately 25 kDa). The chains are held together by disulfide 
bonds. Figure 6.2 depicts the various parts of the molecule which is comprised of 
antigen-binding fragment (Fab) and the constant region (Fc). The constant regions stay 
common for all IgGs and the variable domains are unique [8]. Each IgG has two 
methionine residues, Met 252 and Met 428 (both based on intact heavy chain 





















































D. Formation of sulfoxide (acid catalyzed) 
 


















Figure 6.2: Cartoon of IgG antibody structure. Antibodies bind to the antigen via the 
variable region (VL and VH). L stands for light chain, H for heavy chain. 
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revealed that the methionine residues in the Fc region are susceptible to oxidation 
during storage and exposure to active oxygen species [10-11]. Also, It has been found 
that oxidation of methionine residues accelerate protease cleavage on the CH2 domain 
[9] . Therefore, study of methionine oxidation has become an important area of 
research in the biopharmaceutical industry, especially with the advent of a large 
variety of new therapeutic proteins produced by recombinant DNA technology. 
 Capillary electrophoresis (CE) and more specifically, micellar electrokinetic 
chromatography (MEKC) is a powerful separation technique for proteins, and is 
being used routinely in the industry for preformulation and Quality Control (QC) 
characterization of protein formulations [12]. CE offers the advantages of fast 
analysis times, high resolution, separation efficiency, easy quantitation compared to 
SDS-PAGE gel electrophoresis, easy automation and ability to perform LIF detection 
for high sensitivity analysis.   
 CE separations of proteins are mainly based on charge-to-mass ratio, size, 
ligand interactions and hydrophobic/hydrophilic interactions. The presence of 
negatively charged silanol groups on fused silica capillaries can lead to protein 
adsorption and consequently gives rise to poor resolution/reproducibility, broad peak 
profiles and decreased sensitivity. Another consequence of protein adsorption on 
capillary walls is the nonuniform shielding of negative charge giving rise to 
disorderly EOF patterns within the capillary that contributes to the analytical 
problems discussed previously.  Options to overcome such issues are either to utilize 
capillaries that have been covalently bonded with proprietary polymer coatings or use 
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a polymer solution that uniformly adsorbs on the capillary wall to create a dynamic 
coating. Dynamic coating provides a simple, fast and inexpensive method to modify 
fused silica capillaries for protein/peptide separations using known and characterized 
polymers such as poly(vinyl alcohol) (PVA), cellulose acetate, hydroxypropylmethyl 
cellulose (HPMC), hydroxyethylcellulose (HEC) [13-15]. Although covalently 
bonded capillaries can produce excellent data for very specific applications, use of 
such capillaries for non critical method development can be very expensive and 
therefore impractical [16].   
 Digestion of proteins is a popular method to characterize protein structure. 
The steps include digestion of the protein with an enzyme resulting in the formation 
peptide fragments which can be separated using an appropriate analysis technique. 
The present study aims to investigate the possible use of CE as an alternative to 
HPLC for quantitative characterization of the oxidation of a protein formulation. 
Also, the use of triethanolamine dextran (Bio-Rad CE-SDS gel) as a cheaper 
alternative to commercially coated capillaries for protein analysis was also explored. 
A method was developed to separate the peptide fragment with Met from other 
fragments after Lys-C digestion of the protein. LysC specifically cleaves proteins at 
at the lysine C-terminus which produces lesser number of fragments leading to 
simplified separation compared to Trypsin digest that is most popular in protein 
characterization studies. Also, for oxidation studies involving methionine residues, 
larger peptides lead to improved quantification using UV detection scheme [17]. 
LysC has also been reported to be a robust enzyme capable of withstanding high 
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concentration of denaturants without significant loss of activity. Subsequently, studies 
with protein formulation were presented to compare the performance of covalent 
coated capillaries and dynamic gel coating. 
 
6.2 Materials and Methods 
 All reagents were used as received. Boric acid, sodium phosphate, sodium 
dodecyl sulfate (SDS) were received from Sigma (St. Louis, MO). The monoclonal 
antibody reference standards and the formulations were received from Pfizer (St. 
Louis, MO). The neutral covalently coated capillaries were obtained from Beckman 
(Fullerton, CA). CE-SDS gel buffer was obtained from Bio-Rad (Hercules, CA). 
Endoproteinase Lys-C was obtained from Roche Diagnostics (Manheim, Germany). 
Hydrogen peroxide (30% in water) solution was obtained from Sigma Chemicals (St. 
Louis, MO). 
 All experiments were performed using Beckman PA800 or MDQ systems. 
Sample was introduced into the capillary by utilizing a hydrodynamic injection (5 sec 
at 20psi). Separation was carried out in the reverse polarity mode (negative and 
positive voltage at the injection and detection end respectively). For dynamic coating 
(EOF suppression), the Bio-Rad CE-SDS gel containing triethanolamine dextran as a 
dynamic coating was pressure flushed through 75μm i.d. capillary at 30psi for 30mins 
and then equilibrated for 2 hours. Following this, the capillary was flushed with water 
and buffer to remove excess gel after which analysis was performed.  
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LysC digestion protocol:  Digestion buffer consisting of 25mM Tris HCl, pH 
8.5 and 1mM EDTA was prepared. The lyophilized endoproteinase Lys-C was 
diluted with 5 μL of double distilled water to reach an enzyme concentration of 1 
mg/mL. The monoclonal antibody reference standard was diluted appropriately with 
digestion buffer to reach a concentration of 2 mg/mL. Lys-C (5 μL) was added to 150 
μL of protein solution and incubated for 16 hrs. 
Oxidation studies: Oxidation studies were performed with a final 
concentration of 0.1% H2O2 in the protein digest solution. 
 
6.3 Results and Discussions: 
The choice of the surfactant is the most important decision in MEKC since it 
is a critical factor to obtain the necessary resolution. SDS is the most common anionic 
surfactant used in MEKC. In general, micelles are formed by SDS at a concentration 
above its critical micelle concentration (around 9mM in water). Such micelles in CE 
are often referred to as a “pseudostationary phase” in comparison to the retention 
mechanism in HPLC. Small molecules partition differentially between the 
hydrophobic core and the hydrophilic exterior of the micelle resulting in analyte 
resolution. However, for protein or peptide analytes, the dimension of the micelle (3-
6 nm) cannot accommodate proteins/peptides greater than 5 kDa. Therefore, it is 
generally believed that protein molecules form a complex with SDS by hydrophilic, 
hydrophobic and electrostatic interactions. The degree of complexation with SDS 
varies depending upon the nature of the protein/peptide which results in analyte 
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separation. In addition, the analyte attains a net negative charge due to the anionic 
SDS resulting in high electrophoretic mobility towards the anode. The present study 
employed coated capillaries that suppressed or eliminated EOF within the capillary 
[18]; hence application of reverse polarity aided in reducing the analysis time. 
Preliminary method development studies were performed with a MAb 
reference standard from Pfizer. MEKC separations were performed to identify the 
peptide fragment containing the Met-252 residue which is principally responsible for 
oxidative degradation of the protein. Therefore following LysC digestion, we were 
only interested in the peptide fragment with Met-252 and its oxidized product.  First 
the peak for the peptide fragment was identified by spiking with peptide fraction that 
was isolated from LC. Next, this was confirmed by the addition of 0.1% H2O2 ; it was 
observed that the peak height of the peptide fragment decreases whereas an additional 
peak appears that slowly increases. It was hypothesized that the peak whose height 
increases over time is the oxidized peptide (Fig. 6.3). This idea was further 
investigated later. 
Next buffer optimization studies were performed to determine its effect on the 
separation of the peptide fragment from the oxidized peak. A buffer concentration of 
25 mM borate in 25mM phosphate (pH 8.5) and 5% acetonitrile was found to produce 
the maximum resolution between those 2 species. The study was carried out in a 
covalently bonded capillary so that the separation was only affected by the 
background electrolyte and not by the surface coverage of the polymer adsorbed by 





Figure 6.3: Studies with LC fraction and reference standard with covalently coated 
capillary. The reference standard was oxidized with 0.1% H2O2 and increase and 
decrease of peak heights were observed for proper idetification of the Met-containing 
peptide fragment. CE conditions are as follows:  25 mM borate-phosphate buffer pH 
8.5, 25 mM SDS, 5% acetonitrile, 30 cm neutral coated capillary, UV detection at 
200nm. 
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After establishing peak identity as well as the optimized separation conditions, 
the method developed in the preceding paragraph was tested with two types of 
capillaries i.e. covalent bonded and dynamic coated capillaries. Oxidized species 
were analyzed and the peaks were identified based on appearance/disappearance. 
(Figs. 6.4, 6.5). Based on the previous knowledge of the peptide fragment peak, clear 
trends were observed for increase/decrease of peak heights with both the covalently 
bonded as well as the dynamic coated capillary.  
Although no quantitative measurement was done regarding the total peak area, 
the dynamic coating exhibited better resolution compared to neutral coated capillary. 
We were able to run somewhere between 10-15 runs with the covalent coating before 
non-reproducible data (unresolved peaks) was observed. In general, we were not able 
to use the same capillary for further runs after reapplication of the dynamic coating. It 
has been reported in the literature that some coating (methylcellulose, PVA) materials 
can be removed after rinsing with water [16]. Attempts were made to wash the 
capillary with water, HCl and 1N NaOH. However, subsequent re-coating with gel 
produced highly variable results. For covalent coated capillaries, the number of 
reproducible runs varies greatly (5-20 runs). Such variability can possibly be 
explained by the fact that the coating material was mentioned to be stable between a 
pH range of 3-8. The run buffer used in these experiments (pH 8.5) likely contributed 
to gradual deterioration of the coating material over a few runs.  
 An approach similar to the one described before for reference standards was 





Figure 6.4: Oxidation studies with Bio-Rad gel coating. The reference standard was 
oxidized with 0.1% H2O2 and increase/decrease of peak heights were closely 
observed. The arrows indicate the peaks that appear/disappear. CE conditions: 25 mM 
borate phosphate buffer pH 8.5, SDS 25 mM, acetonitrile 5%, UV detection at 210 
nm, 30 cm capillary with Bio-Rad gel coating. 
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Figure 6.5: Oxidation studies with covalent-coated capillary. The reference standard 
was oxidized with 0.1% H2O2 and increase/decrease of peak heights were closely 
observed. The arrows indicate the peaks that appear/disappear. CE conditions: 25 mM 
borate phosphate buffer pH 8.5, SDS 25 mM, acetonitrile 5%, UV detection at 210 
nm, 30 cm capillary with Bio-Rad gel coating. 
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Ox, t = 70 mins 
Ox, t = 105 mins 
Ox, t = 140 mins 
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Ox, t = 210 mins 
Ox, t = 245 mins 
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identity of the peptide and the corresponding oxidized fragment was confirmed (Fig. 
6.6). To detect the oxidized peak in formulations, a greater quantity of the sample 
needed to be injected in the capillary. This was achieved by increasing the injection 
time to 20 secs. Six sets of formulations were analyzed in neutral coated capillaries 
and with the gel coating. The fraction oxidized was calculated as percent AUC of the 
total AUC for the parent peptide plus the oxidized AUC (Fig. 6.7). The data from 2 
different coating materials is summarized in Table 1. 
 A comparison of values obtained above with HPLC analysis demonstrated 
that the dynamic coating yielded more consistent data. This is surprising as 
commercially available coated capillaries were expected to have better results as the 
covalently coated neutral capillary should have better surface coverage leading to a 
negligible EOF. However, the long injection times may have skewed the calculated 
values as overloading the capillary can give rise to broad peak profiles which makes 
integration difficult and variable. Fluorescence detection of peptides labeled with a 
fluorophore after digestion can be an alternative way to perform more precise 
measurements to draw accurate conclusions. The high sensitivity with LIF detection 
will enable the researcher to inject smaller volumes of sample, yielding sharper peaks 









Figure 6.6: Formulation studies with neutral coated capillaries for identification of 
Met-containing peptide fragment. CE conditions: 25 mM borate-phosphate buffer at 








Figure 6.7: Formulation studies with neutral-coated capillaries (Beckman) showing 
the extent (%) of oxidation from AUC calculations. CE conditions: 25 mM borate-
phosphate buffer at pH 8.5, SDS 25 mM, acetonitrile 5%, UV detection at 210 nm, 30 
cm capillary.  
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Table 6.1: Comparison of oxidation data for 2 kinds of capillary. Calculation was 
done based on the formula 
 
% Ox = (AO/(AO + AP))*100 
 
where, 
% Ox = percent oxidation; AO = peak area of oxidized peptide; AP = Peak area of 
parent peptide. 
 







MAb formulation 1 25C 
 
3.5 2.3 4.41 
MAb formulation 1 40C 
 
7.8 4.3 9.55 
MAb formulation 2 25C 
 
4.7 1.9 Not detected 
MAb formulation 2 40C 
 
7.0 2.5 6.37 
MAb formulation 3 25C 
 
3.9 4.4 4.4 
MAb formulation 3 40C 
 






 This study evaluated the use of coated capillaries for fast separations of 
peptide fragments from a protein digest. Oxidation studies were performed to identify 
the Met-containing peptide fragment that undergoes oxidation. Quantitative analysis 
of protein formulations was performed to compare the extent of oxidation calculated 
using CE with that of HPLC. Overall, a dynamic coating with triethanolamine dextran 
exhibited better performance compared to a neutral coated capillary in terms of 
quantitation and the number of runs that could be performed reproducibly. However, 
a more detailed investigation is necessary to perform a more comprehensive 
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